Sleep disorders

F5_SLEEP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51 Hospital discharge: ICD-9 — 3074 Hospital discharge: ICD-8 — 3064 Cause of death: ICD-10 — F51 Cause of death: ICD-9 — 3074 Cause of death: ICD-8 — 3064 2 out of 7 registries used, show all original rules.	12058
4. Check minimum number of events None	12058
5. Include endpoints F5_INSOMNIA F5_HYPERSOMNIA F5_SLEEPWAKE F5_SLEEPTERRORS F5_NIGHTMARES F5_SLEEP_NOS	68337
6. Filter based on genotype QC (FinnGen only)	61717

Control definitions (FinnGen only)

Control exclude: F5_BEHAVE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F50-F59
Name in latin: Perturbationes somni non organicae

NAME	F5_SLEEP
CONTROL_EXCLUDE	F5_BEHAVE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_INSOMNIA\|F5_HYPERSOMNIA\|F5_SLEEPWAKE\|F5_SLEEPTERRORS\|F5_NIGHTMARES\|F5_SLEEP_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F51
HD_ICD_9	3074
HD_ICD_8	3064
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F51
COD_ICD_9	3074
COD_ICD_8	3064
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	61717	43631	18086
Unadjusted period prevalence (%)	13.38	15.49	8.29
Median age at first event (years)	52.18	50.94	55.18

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
57024: Matched controls
392423

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.5

321.3

1263

2522

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

319.7

12848

63181

F43.01

ICD-10 Finland

Acute stress reaction moderate

3.7

319.1

1161

2196

F50.0

ICD-10 Finland

Anorexia nervosa

47.4

317.8

254

R52.9

ICD-10 Finland

Pain, unspecified

1.8

315.7

5722

23013

-1, ,

ICD-10 Finland

2.2

311.4

2886

9139

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

310.8

14122

71161

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.2

307.7

944

1569

P25

ICPC

Phase of life problem adult

2.5

307.7

2863

8066

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

307.7

7291

26968

N03AX09

ATC

lamotrigine; oral

2.6

307.7

3109

8378

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

307.7

11556

46476

A02BC02

ATC

pantoprazole; systemic

1.6

307.7

37050

208848

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.0

307.7

2811

4968

N76.0

ICD-10 Finland

Acute vaginitis

2.1

307.7

3900

13525

F51

ICD-10 Finland

Nonorganic sleep disorders

7.4

307.7

5418

5460

A03

ICPC

Fever

1.6

307.7

10152

46122

F43.8

ICD-10 Finland

Other reactions to severe stress

4.2

307.7

2354

3994

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.2

307.7

5103

11837

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

307.7

14097

69021

OAB43, ,

SPAT

2.0

307.7

22547

95821

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

307.7

18538

71695

R01AD12

ATC

fluticasone furoate; nasal

1.6

307.7

18508

89313

R06AX27

ATC

desloratadine; oral

1.6

307.7

16622

81096

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

25786

139104

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

25351

123593

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

34.7

307.7

446

N06AB04

ATC

citalopram; systemic

2.4

307.7

13292

44710

P76

ICPC

Depressive disorder

3.1

307.7

5461

13028

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

7605

24615

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.3

307.7

1748

3671

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

35638

202608

OAA81, ,

SPAT

3.1

307.7

2890

6661

A98

ICPC

Health maint/preventive medicine

3.5

307.7

55881

366092

L01

ICPC

Neck symptom/complaint

1.8

307.7

9645

39757

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

307.7

42222

243454

L02

ICPC

Back symptom/complaint

1.8

307.7

5993

23900

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.2

307.7

2989

6618

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.1

307.7

1559

3504

F33

ICD-10 Finland

Recurrent depressive disorder

4.3

307.7

1959

3196

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.8

307.7

4859

9444

N07BB01

ATC

disulfiram; oral

2.7

307.7

2586

6821

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

307.7

7156

27971

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

23887

122300

N02AX02

ATC

tramadol; systemic, rectal

1.6

307.7

22477

114738

N06AA09

ATC

amitriptyline; systemic

2.1

307.7

4808

16457

N06AB10

ATC

escitalopram; oral

3.0

307.7

16919

48388

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.0

307.7

6641

16603

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

13117

54958

N05AX12

ATC

aripiprazole; systemic

2.5

307.7

2569

7203

N06AA06

ATC

trimipramine; systemic

5.0

307.7

1721

2423

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

4.4

307.7

1853

3001

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

307.7

4209

15140

R01AD09

ATC

mometasone; nasal

1.6

307.7

25794

135174

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

307.7

8394

31926

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

31492

172837

L17

ICPC

Foot/toe symptom/complaint

1.5

307.7

16481

82226

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

307.7

2946

6768

P29

ICPC

Psychological sympt/compl other

2.9

307.7

6175

15604

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.4

307.7

4463

9516

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

307.7

2738

7216

P06

ICPC

Sleep disturbance

5.5

307.7

14723

23478

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

307.7

7080

19631

KMAK, ,

NOMESCO Finland

1.5

307.7

27846

155292

N05CF02

ATC

zolpidem; oral

4.3

307.7

16032

32787

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.1

307.7

2329

5268

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

20727

110832

K30

ICD-10 Finland

Functional dyspepsia

1.8

307.7

6322

25244

SPAT1283

SPAT

Restricted health certificate

1.9

307.7

11380

45500

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

11.3

307.7

676

415

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

307.7

1997

4750

F32.1

ICD-10 Finland

Moderate depressive episode

3.7

307.7

5408

10724

N02BE01

ATC

paracetamol; systemic, rectal

2.0

307.7

50334

309988

N03AX12

ATC

[U] gabapentin; oral

1.8

307.7

8371

34289

P01

ICPC

Feeling anxious/nervous/tense

3.3

307.7

12030

29726

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

307.7

3975

12286

GD1AA, ,

SPAT

1.7

307.7

9445

41379

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

307.7

22419

103091

D10

ICPC

Vomiting

2.1

307.7

3755

12686

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

11.0

307.7

3070

2013

N06AX16

ATC

venlafaxine; oral

2.9

307.7

11124

30088

R51

ICD-10 Finland

Headache

2.3

307.7

3647

11272

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

307.7

1697

3742

P15

ICPC

Chronic alcohol abuse

2.9

307.7

1866

4560

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

307.7

51153

322388

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.4

307.7

1364

2803

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

307.7

16192

82827

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

93.3

307.7

337

OAB48, ,

SPAT

1.8

307.7

10749

45368

D01

ICPC

Abdominal pain/cramps general

1.9

307.7

7476

29454

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.0

307.7

2106

5013

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

307.7

2171

4941

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

10640

44006

SFA10

NOMESCO Finland

One-surface restoration

1.4

307.7

30705

175839

R74

ICPC

Upper respiratory infection acute

1.9

307.7

22131

98651

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

78.9

307.7

410

M01AH05

ATC

etoricoxib; oral

1.7

307.7

35165

192760

N06AX12

ATC

bupropion; oral

3.2

307.7

6078

14084

N02BF01

ATC

gabapentin; oral

1.9

307.7

5690

21756

N05BA04

ATC

oxazepam; oral

3.2

307.7

20565

58242

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.0

307.7

1993

4635

R01AD58

ATC

fluticasone, combinations; nasal

1.7

307.7

15284

69121

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

7.7

307.7

679

610

N06AB03

ATC

fluoxetine; oral

2.5

307.7

7811

23392

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.8

307.7

3620

6794

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.4

307.7

1582

3228

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

307.7

11595

27038

F34.1

ICD-10 Finland

Dysthymia

3.3

307.7

2529

5514

N01

ICPC

Headache

2.0

307.7

7522

27580

G43

ICD-10 Finland

Migraine

2.5

307.7

3660

10502

OAB91, ,

SPAT

2.6

307.7

5523

15284

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.5

307.7

1974

3986

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

31531

166271

F50.9

ICD-10 Finland

Eating disorder, unspecified

19.2

307.7

476

172

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

26718

125855

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

307.7

17463

81324

M54

ICD-10 Finland

Dorsalgia

2.0

307.7

7923

29234

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

307.7

571

SPAT1240

SPAT

Therapeutic discussion

2.5

307.7

7569

22627

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

4.0

307.7

2335

4134

N89

ICPC

Migraine

2.6

307.7

2422

6547

N06AB06

ATC

sertraline; oral

2.9

307.7

8671

23127

D11

ICPC

Diarrhoea

2.1

307.7

7885

28262

N06AX26

ATC

vortioxetine; oral

3.5

307.7

6796

14573

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

46015

284373

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

307.7

4096

12547

N05CF01

ATC

zopiclone; oral

3.9

307.7

25535

67216

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

307.7

13531

62656

P74

ICPC

Anxiety disorder/anxiety state

3.4

307.7

3764

8010

OAB93, ,

SPAT

3.5

307.7

6003

12822

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

2.0

307.7

3826

13328

F50.2

ICD-10 Finland

Bulimia nervosa

24.6

307.7

323

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.7

307.7

1562

2973

R83

ICPC

Respiratory infection other

1.7

307.7

16067

74144

N05BA12

ATC

alprazolam; oral

2.4

307.7

5931

18048

OAA65, ,

SPAT

2.8

307.7

15929

47376

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.8

307.7

6830

27061

P02

ICPC

Acute stress reaction

3.5

307.7

4788

9987

F43.2

ICD-10 Finland

Adjustment disorders

3.6

307.7

1283

2471

N03AX16

ATC

[U] pregabalin

1.8

307.7

12213

52207

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

15049

62829

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

14401

67771

L03

ICPC

Low back symptom/complaint

1.8

307.7

17710

79101

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.2

307.7

2353

3947

M03BX02

ATC

tizanidine; oral

1.9

307.7

36468

191472

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.7

307.7

4059

7919

Z73.0

ICD-10 Finland

Burn-out

4.9

307.7

3869

5754

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.5

307.7

1963

3922

G47.3

ICD-10 Finland

Sleep apnoea

1.7

307.7

12504

55391

A02BC05

ATC

esomeprazole; systemic

1.5

307.7

21189

109179

M79.1

ICD-10 Finland

Myalgia

1.9

307.7

8995

35358

Z01.2

ICD-10 Finland

Dental examination

1.4

307.7

26303

146135

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

307.7

6077

17701

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.2

307.7

1566

3422

F32.0

ICD-10 Finland

Mild depressive episode

3.3

307.7

2022

4382

N05AA02

ATC

levomepromazine; systemic

3.4

307.7

2482

5211

J01AA02

ATC

doxycycline; systemic

1.5

307.7

40736

247142

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

5166

R21

ICPC

Throat symptom/complaint

1.7

307.7

13572

60219

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

27637

150404

N05AH03

ATC

olanzapine; systemic

2.7

307.7

4272

11325

N06AA12

ATC

doxepin; systemic

3.2

307.7

3024

6737

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.1

307.7

10188

19702

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.3

307.7

2276

4867

ZY010

NOMESCO Finland

Hospital outpatient

2.3

307.7

2985

9219

N04BC05

ATC

pramipexole; oral

2.3

307.7

4047

12430

F41

ICD-10 Finland

Other anxiety disorders

4.1

307.7

1398

2395

P99

ICPC

Psychological disorders other

2.7

307.7

1967

5079

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

51921

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

19783

90352

Z05

ICPC

Work problem

3.5

307.7

2793

5686

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

307.7

6038

23289

N05AH04

ATC

quetiapine; oral

5.1

307.7

18563

33751

N06BA04

ATC

methylphenidate; oral

3.2

307.7

2578

5800

N06AX21

ATC

duloxetine; oral

2.6

307.7

8326

24310

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

33739

193276

IHZ05, ,

SPAT

2.5

307.7

3226

9104

N05BE01

ATC

buspirone; oral

3.1

307.7

1730

3984

J02AC01

ATC

fluconazole; systemic

1.6

307.7

21539

109636

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.6

307.7

2024

4016

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

30834

171490

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

307.7

38628

226785

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

307.7

3682

11982

Z01.7

ICD-10 Finland

Laboratory examination

1.7

307.7

9160

40675

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.7

307.7

12674

55505

F43.0

ICD-10 Finland

Acute stress reaction

4.2

307.7

5382

9605

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

307.7

10120

45974

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

307.7

28603

161405

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

21264

96824

R51.80

ICD-10 Finland

Headache

2.1

307.7

10318

37402

C07AA05

ATC

propranolol; systemic

2.3

307.7

13523

47141

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.1

307.7

10609

20652

J01FA10

ATC

azithromycin; systemic

1.5

307.7

32146

182645

SFA20

NOMESCO Finland

Two-surface restoration

1.5

307.7

32633

188099

N06AX03

ATC

mianserin; oral

3.9

307.7

3309

6137

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

307.7

3561

7629

F32

ICD-10 Finland

Depressive episode

3.6

307.7

4728

9528

R00.2

ICD-10 Finland

Palpitations

2.0

307.7

4589

16711

G44.2

ICD-10 Finland

Tension-type headache

2.1

307.7

8818

31278

N02BF02

ATC

pregabalin; oral

2.1

307.7

3888

12920

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

307.7

1180

2083

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

5.8

307.7

4177

5249

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

307.7

5484

21449

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

307.7

11386

53882

N05CD07

ATC

temazepam; oral

2.7

307.7

6536

17895

N06AX22

ATC

agomelatine; oral

4.9

307.7

2056

2962

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

307.7

1770

4114

R06.0

ICD-10 Finland

Dyspnoea

1.6

307.7

13628

65814

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

307.7

10230

43367

F43.00

ICD-10 Finland

Acute stress reaction mild

3.2

307.7

1683

3738

R05

ICPC

Cough

1.5

307.7

13445

66225

A04

ICPC

Weakness/tiredness general

2.0

307.7

9868

37325

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

307.7

4013

11629

R42

ICD-10 Finland

Dizziness and giddiness

1.6

307.7

11749

54902

M54.5

ICD-10 Finland

Low back pain

2.0

307.7

23404

102070

J01DB01

ATC

cefalexin; oral

1.6

307.7

46020

283539

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

40632

240387

R06AE07

ATC

cetirizine; oral

1.5

307.7

24015

130780

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

307.7

5704

19656

R05

ICD-10 Finland

Cough

1.6

307.7

11313

53735

N06AX11

ATC

mirtazapine; oral

7.6

307.7

36450

74177

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.2

307.7

2858

4830

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.8

307.7

1187

2181

N06AB05

ATC

paroxetine; oral

2.5

307.7

3587

10186

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

15410

68263

R53

ICD-10 Finland

Malaise and fatigue

2.3

307.7

17210

62551

N03AE01

ATC

clonazepam; systemic

2.3

307.7

3001

9113

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

307.7

34192

162524

P03

ICPC

Feeling depressed

2.9

307.7

8645

22489

N06AX05

ATC

trazodone; oral

6.3

307.7

2203

2492

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.0

307.2

1560

3662

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

304.3

11217

54057

A01

ICPC

Pain general/multiple sites

1.8

302.4

5284

21002

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

297.4

3155

10549

X23

ICPC

Fear sexually transm dis female

2.1

296.5

3113

10366

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

293.0

28157

161939

R11

ICD-10 Finland

Nausea and vomiting

1.9

292.6

4649

17928

N06AG02

ATC

moclobemide; oral

2.4

292.4

2201

6351

R01AD08

ATC

fluticasone; nasal

1.5

291.6

14851

76350

D19

ICPC

Teeth/gum symptom/complaint

1.4

288.8

16996

89741

L12

ICPC

Hand/finger symptom/complaint

1.6

286.9

9315

43563

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

286.1

11254

54892

P58

ICPC

Psychological, Therapeutic counselling/listening

3.0

280.9

1397

3238

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

279.5

3905

14426

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.3

279.1

1181

2476

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.4

276.6

1136

2335

R12

ICD-10 Finland

Heartburn

1.8

276.3

4640

18193

D73

ICPC

Gastroenteritis presumed infection

2.4

276.2

2198

6505

-1, ,

NOMESCO Finland

1.4

275.1

17796

95375

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

274.7

4146

15711

D09

ICPC

Nausea

2.1

271.1

2829

9389

M54.2

ICD-10 Finland

Cervicalgia

1.9

270.4

4294

16539

N05AF03

ATC

chlorprothixene; systemic

2.9

269.9

1441

3480

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

267.3

36727

222348

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.0

265.6

1303

2995

L08

ICPC

Shoulder symptom/complaint

1.5

265.6

11641

57929

N03AG01

ATC

valproic acid; systemic, rectal

2.0

260.2

3065

10651

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.3

258.7

1131

2421

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.0

258.3

1261

2890

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

258.0

6292

27387

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

257.3

21396

119256

R03DC03

ATC

montelukast; oral

1.6

257.3

8493

39762

N30.0

ICD-10 Finland

Acute cystitis

1.5

256.9

8866

41919

J45

ICD-10 Finland

Asthma

1.7

256.9

5504

23144

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.9

253.6

3815

14428

F40.1

ICD-10 Finland

Social phobias

2.7

252.3

1549

4036

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

252.2

1143

2503

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

251.6

2886

9927

N30

ICD-10 Finland

Cystitis

1.8

250.8

4500

17978

S06.0

ICD-10 Finland

Concussion

1.7

248.7

5591

23804

F51.1

ICD-10 Finland

Nonorganic hypersomnia

27.1

247.9

224

J01CA08

ATC

pivmecillinam; oral

1.4

247.9

20536

114186

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

247.5

5151

21473

IBA01, ,

SPAT

2.9

247.5

1329

3219

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

246.9

6378

28148

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

246.5

6292

27684

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

245.4

21877

123008

F50.1

ICD-10 Finland

Atypical anorexia nervosa

25.8

244.3

224

K08.80

ICD-10 Finland

Toothache NOS

1.7

243.3

4987

20696

R02

ICPC

Shortness of breath/dyspnoea

1.6

243.1

6763

30387

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

242.3

3583

13468

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

241.1

4128

16253

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.8

240.8

826

1496

M79.7

ICD-10 Finland

Fibromyalgia

2.4

238.5

1924

5724

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.4

238.0

691

1098

A02BC03

ATC

lansoprazole; oral

1.4

236.4

13038

67538

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

236.0

1579

4298

IHZ04, ,

SPAT

3.0

235.1

1154

2653

R52.2

ICD-10 Finland

Other chronic pain

2.3

234.1

1984

6033

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

233.5

10435

51938

OAA67, ,

SPAT

1.5

232.1

9726

47786

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

230.9

5773

25240

H01

ICPC

Ear pain/earache

1.6

230.1

6495

29255

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

230.0

2867

10158

R07.0

ICD-10 Finland

Pain in throat

1.8

229.8

4092

16292

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

229.7

6014

26598

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

229.6

1004

2149

M77.1

ICD-10 Finland

Lateral epicondylitis

1.8

229.4

4304

17402

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

229.1

11351

57597

L15

ICPC

Knee symptom/complaint

1.4

228.6

12712

65879

J20

ICD-10 Finland

Acute bronchitis

1.7

227.9

5396

23258

N06BA12

ATC

lisdexamfetamine; oral

3.8

227.7

785

1427

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

227.5

9279

45319

N17

ICPC

Vertigo/dizziness

1.6

226.8

6253

28000

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.0

226.1

1127

2614

D06

ICPC

Abdominal pain localized other

1.7

224.7

4809

20174

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

223.8

3805

14936

A97

ICPC

No disease

1.5

223.1

10245

51204

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.7

222.6

813

1541

R07

ICPC

Sneezing/nasal congestion

1.8

222.6

3687

14356

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.3

220.9

934

1956

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

220.7

6488

29486

SPAT1051

SPAT

Guidance regarding sleep disorders

3.3

220.3

928

1939

Z2445

NOMESCO Finland

Psychologist

2.2

220.0

2043

6458

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.8

219.0

764

1401

SPAT1308

SPAT

Sexual health counselling

1.6

218.4

6338

28712

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.7

218.3

1280

3253

F50.3

ICD-10 Finland

Atypical bulimia nervosa

20.0

217.9

217

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

217.6

3779

14924

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.3

216.0

918

1929

N06AB08

ATC

fluvoxamine; oral

2.7

215.7

1315

3412

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

213.0

5864

26223

A02BC01

ATC

omeprazole; systemic

1.4

212.0

12569

65729

A05

ICPC

Feeling ill

1.8

212.0

3491

13562

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

211.2

20645

116888

F32.8

ICD-10 Finland

Other depressive episodes

3.1

210.9

982

2186

E66

ICD-10 Finland

Obesity

1.9

210.7

2972

10983

N02CC07

ATC

frovatriptan; oral

2.1

209.1

2131

6993

E0000UV, ,

ATC

1.3

208.0

21421

122128

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

2.0

207.5

2507

8776

R06AX22

ATC

ebastine; oral

1.5

206.0

8545

41783

H02AB06

ATC

prednisolone; systemic

1.3

205.9

23264

134353

O99.80

ICD-10 Finland

The fear of childbirth

2.1

205.1

2308

7870

P16

ICPC

Acute alcohol abuse

3.1

204.2

959

2146

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.8

202.2

1154

2890

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

202.0

4367

18345

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.6

201.7

5961

27084

U02

ICPC

Urinary frequency/urgency

1.5

201.4

7319

34814

E66.8

ICD-10 Finland

Other obesity

1.9

200.7

2902

10809

Z2221

NOMESCO Finland

Medical doctor

1.4

200.1

12880

68188

D82

ICPC

Teeth/gum disease

1.3

199.8

20049

113678

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.0

199.7

362

360

K59.0

ICD-10 Finland

Constipation

1.9

199.3

2654

9614

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

198.3

7034

33278

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

197.8

13276

70747

R07.3

ICD-10 Finland

Other chest pain

1.6

197.6

4964

21679

SDA03

NOMESCO Finland

Periodontal treatment

1.3

197.3

21488

123202

T74.1

ICD-10 Finland

Physical abuse

2.8

196.6

1125

2821

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.1

195.8

2057

6829

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

195.8

1905

6135

M01AC06

ATC

meloxicam; systemic, rectal

1.3

193.9

16673

92303

A02BC04

ATC

rabeprazole; oral

1.7

193.8

4235

17834

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.0

193.4

956

2206

F31

ICD-10 Finland

Bipolar affective disorder

3.4

192.6

773

1564

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

192.4

6902

32713

R01AD59

ATC

mometasone, combinations; nasal

1.7

189.8

3645

14807

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

189.6

5033

22269

SGA01

NOMESCO Finland

Emergency treatment

1.5

188.5

8486

42089

J01DA01

ATC

[U] cefalexin

1.3

188.4

30945

187168

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

187.3

1036

2550

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

186.4

1736

5489

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

185.0

2600

9586

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

184.7

3042

11803

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.1

184.6

575

967

F50.8

ICD-10 Finland

Other eating disorders

17.0

184.2

195

N05AX08

ATC

risperidone; systemic

1.7

184.1

3700

15219

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

183.8

3058

11901

K58

ICD-10 Finland

Irritable bowel syndrome

2.3

183.4

1511

4533

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

183.0

4407

19023

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

181.4

3173

12537

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

181.2

4813

21286

EBA00

NOMESCO Finland

Extraction of tooth

1.3

181.2

18836

106916

S18

ICPC

Laceration/cut

1.3

181.1

22875

133331

Z00.0

ICD-10 Finland

General medical examination

1.4

181.1

9382

47720

SPAT1310

SPAT

Counselling related to known health issue

1.3

181.0

15314

84380

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

180.9

4090

17365

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

180.8

3014

11736

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

180.2

19282

109860

J01FA06

ATC

roxithromycin; oral

1.3

180.1

18710

106164

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

179.2

2365

8533

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

179.1

14711

80671

L16

ICPC

Ankle symptom/complaint

1.5

179.1

6087

28486

A11

ICPC

Chest pain NOS

1.7

177.9

3970

16796

A23

ICPC

Risk factor NOS

1.6

177.5

5123

23105

EB1AA, ,

SPAT

1.8

177.2

3229

12910

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.7

176.7

1093

2856

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

176.1

8705

43877

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

175.3

915

2179

M54.8

ICD-10 Finland

Other dorsalgia

1.9

175.3

2374

8641

K04.08

ICD-10 Finland

Other specified pulpit

1.6

174.6

4170

17952

H92.0

ICD-10 Finland

Otalgia

1.7

174.3

3390

13810

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

173.8

3872

16369

SFA30

NOMESCO Finland

Three-surface restoration

1.3

173.7

21082

122011

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

173.4

3623

15054

S29

ICPC

Skin symptom/complaint other

1.4

173.3

9959

51534

P18

ICPC

Medication abuse

4.9

172.9

439

621

R30.0

ICD-10 Finland

Dysuria

2.0

171.9

2215

7925

DM1QA, ,

SPAT

1.9

171.5

2296

8323

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

171.3

3982

17020

N05BA02

ATC

chlordiazepoxide; systemic

2.7

171.3

1050

2731

N05AN01

ATC

lithium; oral

2.5

171.3

1231

3467

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.1

171.1

801

1789

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

170.6

4001

17140

Z3231

NOMESCO Finland

Registered nurse

1.4

170.6

12389

66580

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.6

170.5

640

1237

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

170.5

8487

42805

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

169.0

11737

62618

SPAT1192

SPAT

Gynaecological examination

1.6

169.0

4547

20157

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

168.6

16514

92717

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

168.2

17331

97985

G03DB01

ATC

dydrogesterone; oral

1.5

167.9

5758

26973

IGY02, ,

SPAT

2.8

167.5

951

2374

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

167.3

2204

7945

N02CC04

ATC

rizatriptan; oral

1.8

167.1

2800

10913

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

166.9

10803

56970

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

166.9

15065

83584

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

166.8

6505

31296

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

166.1

1648

5345

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

165.6

3149

12739

SPAT1263

SPAT

Sampling

1.3

165.4

20602

119398

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

165.3

756

1664

J01

ICD-10 Finland

Acute sinusitis

1.8

164.7

2907

11507

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.8

164.6

915

2258

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.8

164.5

2989

11934

ZXE00

NOMESCO Finland

One hour or less

1.3

164.1

18153

103537

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

163.8

11039

58570

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.2

163.3

746

1641

J01EA01

ATC

trimethoprim; systemic

1.4

162.4

11772

63165

R03BA02

ATC

budesonide; inhalant

1.4

162.1

8480

43109

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

162.0

3645

15440

F10.24

ICD-10 Finland

Alcohol depence active use

3.0

161.5

816

1907

U07

ICPC

Urine symptom/complaint other

1.6

161.5

3936

17020

M77.4

ICD-10 Finland

Metatarsalgia

1.7

160.4

3030

12232

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

159.2

3038

12300

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

158.8

4196

18507

S80.0

ICD-10 Finland

Contusion of knee

1.6

158.5

3868

16726

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

157.5

2710

10643

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

157.0

966

2517

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

156.8

830

1993

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

156.7

9346

48561

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.6

156.6

574

1091

X58

ICD-10 Finland

Exposure to other specified factors

1.4

156.0

7462

37302

AA1AD

NOMESCO Finland

CT of head and brain

1.3

155.9

12536

68258

C09CA06

ATC

candesartan; oral

1.4

155.9

11298

60559

R09

ICPC

Sinus symptom/complaint

1.6

155.3

4178

18504

W12

ICPC

Contraception intrauterine

1.6

155.2

4645

21091

J30.19

ICD-10 Finland

Pollen allergy UNS

1.9

155.0

2237

8312

F41.00

ICD-10 Finland

Moderate panic disorder

2.8

154.9

862

2128

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

154.6

3145

12960

B02AA02

ATC

tranexamic acid; systemic

1.5

154.5

6809

33515

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

154.3

4506

20344

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.7

154.2

3020

12313

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

154.2

14384

79988

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

154.1

1333

4083

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

153.8

13034

71496

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.0

153.7

778

1820

R03BA05

ATC

fluticasone; inhalant

1.4

153.7

8630

44371

K07.60

ICD-10 Finland

Snapping jaw

1.8

153.6

2654

10435

X15

ICPC

Vaginal symptom/complaint other

1.9

153.5

2118

7753

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

153.3

10182

53819

J01FA09

ATC

clarithromycin; systemic

1.3

153.0

15046

84265

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

152.9

14156

78618

R06AE09

ATC

levocetirizine; oral

1.4

152.9

6937

34327

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

152.8

5718

27245

N02CC05

ATC

almotriptan; oral

2.0

152.7

1945

6926

SPAT1312

SPAT

General health counselling

1.3

151.8

15520

87365

WX110, ,

SPAT

1.8

151.3

2794

11200

R06.5

ICD-10 Finland

Mouth breathing

1.6

150.4

4151

18490

Z2446

NOMESCO Finland

Social worker

1.7

150.4

2866

11594

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.8

150.0

2729

10892

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.7

149.8

895

2296

G43.3

ICD-10 Finland

Complicated migraine

2.6

148.2

943

2500

N05AB03

ATC

perphenazine; systemic, rectal

2.1

148.1

1553

5146

U01

ICPC

Dysuria/painful urination

1.6

146.8

3882

17112

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

146.7

2321

8880

N05CD02

ATC

nitrazepam; oral

3.2

146.5

661

1443

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.4

146.3

9207

48196

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.8

146.1

797

1946

K04.0

ICD-10 Finland

Pulpitis

1.5

145.8

4608

21166

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

145.3

13109

72441

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

145.1

17852

102806

D12

ICPC

Constipation

2.0

145.0

1702

5885

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

33.9

144.0

123

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

144.0

4375

19917

OAA62, ,

SPAT

1.6

143.0

4092

18372

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

142.7

1045

2969

N02CC03

ATC

zolmitriptan; nasal, oral

1.8

142.3

2520

9975

N03AX11

ATC

topiramate; oral

2.3

141.8

1214

3701

IGY99, ,

SPAT

2.3

141.5

1197

3630

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.3

141.5

279

306

N07BA03

ATC

varenicline; oral

1.8

141.5

2364

9196

Z63.4

ICD-10 Finland

Disappearance and death of family member

3.1

141.5

655

1453

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.4

140.7

10095

53907

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

140.7

3914

17456

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

140.5

2638

10621

L13

ICPC

Hip symptom/complaint

1.4

140.4

8650

45089

F60.5

ICD-10 Finland

Anankastic personality disorder

3.2

140.3

622

1343

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

131.9

140.2

172

D07AC01

ATC

betamethasone; topical

1.3

140.0

17362

99967

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

2.2

139.6

1286

4045

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

139.4

5211

24796

T82

ICPC

Obesity

1.8

138.6

2146

8153

N02CC06

ATC

eletriptan; oral

2.0

138.2

1767

6299

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

137.3

4727

22107

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

137.1

3525

15423

R35

ICD-10 Finland

Polyuria

1.7

136.7

2855

11840

Z12

ICPC

Relationship problem with partner

2.5

136.7

939

2587

D02

ICPC

Abdominal pain epigastric

1.7

136.4

3048

12869

J01AA07

ATC

tetracycline; systemic

1.4

136.1

6969

35187

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.7

136.1

829

2149

H03AA01

ATC

levothyroxine sodium; systemic

1.3

135.5

10463

56447

J05AB01

ATC

aciclovir; systemic

1.3

135.5

10165

54606

L11

ICPC

Wrist symptom/complaint

1.5

134.8

4630

21637

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

134.1

5216

25008

W11

ICPC

Contraception oral

1.5

133.7

4538

21151

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

133.7

19543

114628

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.8

133.5

2166

8348

Z10.0

ICD-10 Finland

Occupational health examination

1.5

133.5

5008

23835

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

133.0

3851

17328

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

132.5

4363

20202

A02BA02

ATC

ranitidine; systemic

1.4

132.5

7621

39241

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

132.4

13533

75887

NH3AA, ,

SPAT

1.7

132.3

2889

12122

EMB10

NOMESCO Finland

Tonsillectomy

1.7

132.2

2907

12220

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

131.5

3311

14407

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

131.3

3605

16018

G02BA03

ATC

plastic IUD with progestogen

1.5

131.2

5229

25185

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.4

131.1

1037

3053

R03BA01

ATC

beclometasone; inhalant

1.4

130.7

6105

30303

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.5

130.4

4150

19070

A99

ICPC

Disease/condition unspecnature/site

1.5

130.4

4776

22614

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.5

130.2

506

1002

F29

ICPC

Eye symptom/complaint other

1.5

130.2

5072

24317

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

129.7

3335

14584

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

23.4

129.2

122

H01.0

ICD-10 Finland

Blepharitis

1.6

129.1

3402

14966

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

129.0

7104

36295

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.4

128.7

293

374

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

128.6

4833

23001

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

128.4

4156

19165

R01AD01

ATC

beclometasone; nasal

1.4

128.3

6789

34447

M75.8

ICD-10 Finland

Other shoulder lesions

1.9

127.9

1858

6912

ULA02

NOMESCO Finland

Kolposcopy

1.5

127.7

4260

19772

R06AX13

ATC

loratadine; oral

1.4

127.4

7093

36301

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.9

127.2

425

755

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

127.1

3462

15349

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

126.5

2902

12330

G47.8

ICD-10 Finland

Other sleep disorders

2.4

126.5

994

2917

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

126.5

14040

79487

H93.1

ICD-10 Finland

Tinnitus

1.6

126.3

3190

13888

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

126.2

11286

62085

W14

ICPC

Contraception female other

1.7

126.2

2466

10036

K03.80

ICD-10 Finland

Irradiated enamel

1.7

125.8

2727

11416

R4110

NOMESCO Finland

Physiotherapy

1.3

125.7

12440

69376

M01AH01

ATC

celecoxib; oral

1.4

125.6

7591

39375

SPAT1260

SPAT

Consultation of another employee

1.4

125.4

7858

40996

Z3226

NOMESCO Finland

Physiotherapist

1.4

125.0

7659

39813

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

124.9

4944

23767

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

124.2

2435

9918

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

123.7

2704

11343

H57.1

ICD-10 Finland

Ocular pain

1.8

123.6

1943

7412

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

3.8

123.6

432

794

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

123.4

20162

119461

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.5

123.3

4228

19732

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.9

123.1

1702

6229

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

122.6

3538

15895

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

122.5

2006

7750

K04

ICPC

Palpitations/awareness of heart

1.7

122.4

2450

10035

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

122.0

830

2276

NG1AA, ,

SPAT

1.5

121.1

3900

17955

P27

ICPC

Fear of mental disorder

2.7

120.8

720

1845

G01AA10

ATC

clindamycin; vaginal

1.4

120.8

6280

31741

OAA64, ,

SPAT

1.6

120.6

2910

12521

LCH11

NOMESCO Finland

Pharmacologic abortion

1.9

120.2

1690

6219

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

120.0

6824

35016

L20.0

ICD-10 Finland

Besnier prurigo

1.5

120.0

3677

16742

IHZ01, ,

SPAT

2.7

120.0

713

1824

EB1VA, ,

NOMESCO Finland

1.3

119.7

8819

47139

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.0

119.6

584

1338

IAA01, ,

SPAT

3.2

119.5

543

1191

XQ800

NOMESCO Finland

Prick test

1.6

119.3

3424

15360

JN1AE, ,

SPAT

1.8

119.3

1969

7625

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

119.2

1331

4515

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.4

119.1

6226

31490

R03AC03

ATC

terbutaline; inhalant

1.4

119.1

6191

31283

R50.9

ICD-10 Finland

Fever, unspecified

1.4

118.9

6915

35612

R52.0

ICD-10 Finland

Acute pain

1.9

118.8

1577

5692

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

118.5

18222

107088

WZC00, ,

SPAT

1.4

118.4

7302

37963

Z56.6

ICD-10 Finland

Other physical and mental strain related to work

3.5

118.4

468

938

NA3BG, ,

SPAT

1.8

118.3

2080

8208

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

118.3

1343

4585

J06.89

ICD-10 Finland

Other acute upper respiratory infections of multiple sites

2.0

117.7

1326

4513

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.5

117.7

4210

19817

ND2AA, ,

SPAT

1.6

117.2

2741

11698

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

117.2

2999

13092

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.3

117.0

492

1027

L04

ICPC

Chest symptom/complaint

1.6

116.9

2999

13100

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

116.8

4294

20325

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

116.6

2180

8757

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

116.6

14809

85073

Z29

ICPC

Social problem NOS

2.2

116.4

1060

3317

F43.28

ICD-10 Finland

Adaptive disorder with other predominant symptoms

4.1

116.4

363

612

X14

ICPC

Vaginal discharge

2.1

116.3

1213

4010

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.8

115.6

297

425

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.5

114.9

810

2260

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

114.4

5829

29336

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

114.1

14020

80172

E61.1

ICD-10 Finland

Iron deficiency

2.0

113.6

1367

4767

SPAT1301

SPAT

No procedures

1.3

113.5

14199

81366

P19

ICPC

Drug abuse

3.0

113.2

557

1282

F51.5

ICD-10 Finland

Nightmares

14.3

113.1

129

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

113.1

1930

7549

SPAT1238

SPAT

Brief therapy

2.3

113.0

903

2670

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

113.0

3937

18422

NA3AA, ,

SPAT

1.8

113.0

1846

7125

J02

ICD-10 Finland

Acute pharyngitis

1.8

112.8

2035

8091

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.3

112.5

954

2896

G03HB01

ATC

cyproterone and estrogen; oral

1.5

111.1

4267

20365

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.7

111.0

650

1650

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

111.0

4389

21070

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

110.9

2007

7987

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.0

110.7

557

1299

Z00.8

ICD-10 Finland

Other general examinations

1.5

110.5

3783

17635

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

110.4

15459

89706

K05.22

ICD-10 Finland

Acute pericoronitis

1.7

110.2

2275

9393

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

110.0

12432

70308

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

110.0

1951

7718

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

109.9

10352

57190

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

43.8

109.8

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

109.7

2190

8959

L18

ICPC

Muscle pain

1.7

109.5

2016

8062

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.7

109.2

2069

8342

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

109.0

12275

69376

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.5

108.8

739

2025

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.5

108.7

4068

19310

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

108.6

3001

13336

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

108.2

2683

11615

J04.0

ICD-10 Finland

Acute laryngitis

1.8

108.2

1762

6793

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

107.6

16459

96397

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

107.5

8055

43084

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

107.5

5028

24907

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

107.4

2476

10525

WX402

NOMESCO Finland

General anaesthesia

1.3

107.1

10500

58287

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

107.0

2096

8530

J01AA04

ATC

lymecycline; systemic

1.4

106.9

6168

31680

K80

ICPC

Cardiac arrhythmia NOS

1.5

106.7

3667

17101

H10

ICD-10 Finland

Conjunctivitis

1.5

106.7

3638

16940

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.6

106.3

686

1832

L86

ICPC

Back syndrome with radiating pain

1.6

105.8

2765

12124

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

105.5

8679

47038

G44.8

ICD-10 Finland

Other specified headache syndromes

2.4

105.3

773

2199

R06AX26

ATC

fexofenadine; oral

1.6

104.7

3102

14005

M54.3

ICD-10 Finland

Sciatica

1.6

104.3

2563

11069

R29

ICPC

Respiratory symptom/complaint other

1.6

104.0

3117

14109

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.6

103.9

672

1797

C07AB07

ATC

bisoprolol; oral

1.2

103.8

20426

122771

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

103.7

10829

60567

ZYC01, ,

SPAT

1.4

103.4

5275

26527

N05AB01

ATC

dixyrazine; systemic

3.0

103.0

513

1190

V03AA01, ,

ATC

2.6

102.8

656

1742

ZYC02, ,

SPAT

1.8

102.4

1602

6100

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.5

102.3

3907

18612

N94.4

ICD-10 Finland

Primary dysmenorrhoea

2.2

102.3

955

3019

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

102.3

21371

129175

D07AA02

ATC

hydrocortisone; topical

1.4

101.5

6396

33297

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

101.1

3772

17884

L10

ICPC

Elbow symptom/complaint

1.6

101.0

2625

11491

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

101.0

2401

10282

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.2

100.7

899

2790

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

100.7

2146

8934

S04

ICPC

Lump/swelling localized

1.4

100.4

5174

26056

K03.00

ICD-10 Finland

Approximal wear

1.5

100.3

3637

17144

SGC10

NOMESCO Finland

Pulp capping

1.5

99.8

4143

20057

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.2

99.6

877

2706

JN3AE, ,

SPAT

1.7

99.2

1872

7536

L05

ICPC

Flank/axilla symptom/complaint

1.6

99.2

2829

12659

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

99.1

2049

8461

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

4.1

98.9

312

531

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

2.9

98.2

503

1186

IHZ19, ,

SPAT

2.8

98.1

530

1288

L09

ICPC

Arm symptom/complaint

1.6

97.6

2270

9666

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.6

97.5

362

695

F43.02

ICD-10 Finland

Acute stress reaction severe

4.1

97.4

301

504

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

97.2

1076

3638

S21

ICPC

Skin texture symptom/complaint

1.3

96.8

6853

36296

ZY000

NOMESCO Finland

Hospital inpatient

2.6

96.6

632

1700

ICB06, ,

NOMESCO Finland

3.3

96.5

409

859

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

96.1

1390

5161

E03

ICD-10 Finland

Other hypothyroidism

1.6

96.1

2629

11649

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

96.0

4919

24736

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

95.8

2118

8902

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

95.3

4527

22461

N62

ICD-10 Finland

Hypertrophy of breast

1.7

94.9

1795

7230

WX723

NOMESCO Finland

CPAP therapy

1.7

94.5

1945

8020

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

94.4

1488

5678

UJF32

NOMESCO Finland

Coloscopy

1.3

94.4

11032

62458

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.9

94.1

1240

4462

N06AA10

ATC

nortriptyline; systemic

2.2

94.1

911

2924

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.0

93.7

470

1095

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

93.6

9674

53939

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

93.5

3321

15581

R45

ICD-10 Finland

Symptoms and signs involving emotional state

3.7

93.3

328

606

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

93.1

5082

25824

A06AC51

ATC

ispaghula, combinations; oral

1.7

93.1

1983

8252

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.8

93.1

1676

6656

H29

ICPC

Ear symptom/complaint other

1.4

93.0

5331

27308

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

93.0

1522

5875

L28

ICPC

Limited function/disability (L)

1.3

92.8

7611

41150

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

92.8

4457

22154

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

92.4

3208

14978

X02

ICPC

Menstrual pain

2.0

92.4

1157

4091

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

2.1

92.3

937

3065

G43.8

ICD-10 Finland

Other migraine

2.3

92.1

757

2267

130

Kela drug reimbursment

Malignant tumour

0.6

92.1

1383

16557

G54.0

ICD-10 Finland

Brachial plexus disorders

2.0

91.9

1175

4185

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.8

91.5

517

1288

R03BA08

ATC

ciclesonide; inhalant

1.5

91.5

3818

18490

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.5

91.2

2892

13244

N06AA04

ATC

clomipramine; systemic

2.4

91.2

715

2097

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

91.0

4547

22755

S02

ICPC

Pruritus

1.7

91.0

1696

6803

OAB38, ,

SPAT

2.0

90.7

1096

3827

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

90.3

11315

64533

R25.2

ICD-10 Finland

Cramp and spasm

2.0

90.0

1121

3956

R96

ICPC

Asthma

1.4

89.8

4315

21444

H60

ICD-10 Finland

Otitis externa

1.6

89.7

2485

11040

Z30.2

ICD-10 Finland

Sterilization

1.4

89.5

4353

21679

J01FF01

ATC

clindamycin; systemic

1.2

89.2

12049

69301

IEY01

NOMESCO Finland

Psychoeducation, individual

3.0

89.0

438

1009

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.9

88.9

1156

4141

WX780

NOMESCO Finland

Remote monitoring CPAP

1.7

88.4

1963

8257

IHZ02, ,

SPAT

2.3

88.1

771

2373

K05.32

ICD-10 Finland

Periodontitis NOS

1.4

87.5

3658

17715

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

87.5

2092

8968

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

87.3

2067

8838

P48

ICPC

Psychological, Clarification/discussion RFE/demand

3.3

87.3

367

767

L70.0

ICD-10 Finland

Acne vulgaris

1.8

87.3

1462

5683

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.9

87.3

456

1088

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.3

87.1

363

754

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.5

87.1

2720

12413

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.9

87.0

1168

4230

EB1SA, ,

SPAT

1.6

86.9

2373

10505

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

86.6

2469

11039

N05CD08

ATC

midazolam; nasal, systemic

2.2

86.4

839

2696

Z72.1

ICD-10 Finland

Alcohol use

2.5

86.3

578

1573

K04.09

ICD-10 Finland

Pulpit UNS

1.6

86.3

2158

9353

D10BA01

ATC

isotretinoin; oral

1.5

86.1

3099

14571

NB1AA, ,

SPAT

1.7

86.0

1917

8070

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

86.0

4286

21427

Z3232

NOMESCO Finland

Midwife

1.5

86.0

3194

15114

D10AX03

ATC

azelaic acid; topical

1.5

85.9

3382

16191

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

85.2

1976

8404

D03

ICPC

Heartburn

1.7

85.2

1680

6845

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

5.2

85.0

203

272

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.7

85.0

1709

7001

WX290, ,

SPAT

1.7

84.9

1577

6318

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.8

84.7

458

1114

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

84.7

17788

106985

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

84.7

4057

20142

SFA00

NOMESCO Finland

Small restoration

1.3

84.6

6349

33861

T83

ICPC

Overweight

1.9

84.5

1116

4019

SPAT1389

SPAT

Visit based on need for special support

2.0

84.5

1047

3688

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

84.5

1306

4952

SPAT1265

SPAT

Breathalyser

2.9

84.5

452

1093

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

84.2

2323

10308

P81

ICPC

Hyperkinetic disorder

2.9

84.1

444

1066

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.0

83.9

1069

3803

L29

ICD-10 Finland

Pruritus

2.2

83.8

752

2339

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

83.8

8336

46177

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

2.0

83.7

984

3402

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

83.6

1645

6698

WZB00, ,

SPAT

1.4

83.6

4801

24578

J01MA02

ATC

ciprofloxacin; systemic

1.2

83.3

16909

101316

N06AX18

ATC

reboxetine; oral

2.8

83.2

477

1198

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.5

83.2

600

1693

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.4

83.2

5086

26297

T07

ICPC

Weight gain

2.2

82.8

784

2494

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.6

82.7

538

1444

A29

ICPC

General symptom/complaint other

1.3

82.6

5729

30200

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

82.5

4343

21910

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.3

82.3

5545

29101

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

82.2

5977

31723

G04BD12

ATC

mirabegron; oral

1.4

82.1

4575

23300

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

5.9

82.1

172

202

IAB01, ,

SPAT

3.3

81.7

342

713

S82

ICPC

Naevus/mole

1.3

81.7

6472

34772

C05AA08

ATC

fluocortolone; rectal, topical

1.3

81.6

5479

28735

N63

ICD-10 Finland

Unspecified lump in breast

1.5

81.5

2970

13995

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.6

81.5

2338

10466

WZA00, ,

SPAT

1.9

81.4

1076

3877

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.7

81.4

1628

6659

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

81.3

5691

30033

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.6

81.3

1921

8209

Z30.8

ICD-10 Finland

Other contraceptive management

1.8

81.2

1266

4813

D06BB04

ATC

podophyllotoxin; topical

1.6

81.0

2256

10031

N64.4

ICD-10 Finland

Mastodynia

1.7

80.9

1529

6156

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

2.0

80.9

1006

3549

Z72.2

ICD-10 Finland

Drug use

3.5

80.8

314

623

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.7

80.5

1719

7155

M77.0

ICD-10 Finland

Medial epicondylitis

1.9

80.5

1184

4420

SPAT1254

SPAT

Administration of medicine

1.3

80.4

6205

33208

R08

ICPC

Nose symptom/complaint other

1.7

80.1

1579

6432

WZA00

NOMESCO Finland

Concise certificate

1.5

80.0

2925

13792

L84

ICPC

Back syndrome without radiat pain

1.6

80.0

2040

8882

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

79.7

5030

26128

ICB01, ,

SPAT

2.7

79.7

471

1203

S50.0

ICD-10 Finland

Contusion of elbow

1.8

79.7

1415

5596

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

79.5

11102

63955

N06BA09

ATC

atomoxetine; oral

4.2

79.5

238

389

M02AA07

ATC

piroxicam; topical

1.2

79.4

14886

88416

R19.4

ICD-10 Finland

Change in bowel habit

1.8

78.9

1266

4857

M54.1

ICD-10 Finland

Radiculopathy

1.7

78.8

1653

6848

Z08

ICPC

Social welfare problem

2.4

78.8

613

1792

SBB10

NOMESCO Finland

Dental impressions

1.5

78.7

3090

14777

S22.3

ICD-10 Finland

Fracture of rib

1.5

78.6

2890

13641

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

78.5

5659

29983

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.8

78.1

442

1103

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

3.5

77.9

302

598

IGV01

NOMESCO Finland

Psychiatric network contact

2.6

77.7

509

1371

A06AD11

ATC

lactulose; oral

1.3

77.7

5239

27485

U71

ICPC

Cystitis/urinary infection other

1.5

77.4

2992

14263

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002030) Lymphocytes/Leukocytes in Blood

29002

166475

1.40

314.74

6.1

6.7

29.11

28.19

42.84

27655

158484

(3001019) Free T4 and TSH panel - Serum or Plasma

4699

17832

1.89

311.72

1.7

1.6

—

(3006504) Eosinophils/Leukocytes in Blood

28204

161422

1.40

308.83

6.1

6.8

2.86

2.83

1.30

26587

152052

(3019069) Monocytes/Leukocytes in Blood

28261

161849

1.40

307.96

6.2

6.9

8.58

8.76

24.27

26672

152548

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

52723

311345

3.19

307.65

6.4

5.2

1.76

1.87

mu/l

38.42

50483

290967

(3020564) Creatinine [Moles/volume] in Serum or Plasma

55483

356430

3.64

307.65

19.7

18.9

73.49

75.80

umol/l

68.96

55123

352502

(3019550) Sodium [Moles/volume] in Serum or Plasma

53516

335685

2.58

307.65

17.8

17.1

139.57

139.68

mmol/l

19.24

52773

329031

(46235355) HIV 1 and 2 tests - Meaningful Use set

15734

76810

1.57

307.65

2.3

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

31772

179728

1.49

307.65

6.0

6.6

1.98

1.92

e9/l

6.43

28183

159269

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

56438

370282

5.76

307.65

25.3

22.9

41.11

41.06

0.10

56156

366670

(3011288) Drugs identified in Urine by Screen method Nominal

4194

11493

2.63

307.65

3.4

2.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

4529

14247

2.29

307.65

1.9

1.7

0.29

0.31

mg/l

1.43

2288

6743

(3018010) Neutrophils/Leukocytes in Blood

28664

163306

1.42

307.65

6.0

6.6

56.30

57.09

27.26

27483

156599

(3007461) Platelets [#/volume] in Blood

56426

370093

5.69

307.65

24.9

22.5

259.25

254.06

e9/l

70.99

55787

362881

(3007164) IgA [Mass/volume] in Serum or Plasma

15310

71991

1.63

307.65

1.5

2.25

2.36

g/l

12.02

9711

45669

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

43843

248695

1.92

307.65

4.5

4.3

9.96

11.45

mm/h

120.00

41620

233794

(3013650) Neutrophils [#/volume] in Blood by Automated count

33969

196258

1.47

307.65

8.2

10.0

4.04

4.09

e9/l

3.84

29574

170871

(3037467) Urinalysis macro (dipstick) panel - Urine

39364

232419

1.53

307.65

4.7

4.5

11.44

41.62

0.34

338

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12356

59671

1.54

307.65

1.4

1.3

7.18

11.40

u/ml

12.50

5056

23644

(3015377) Calcium [Moles/volume] in Serum or Plasma

21582

112123

1.52

307.65

2.8

3.6

2.35

2.36

mmol/l

0.35

19825

102668

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7698

29264

1.94

307.65

2.6

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

12336

48773

1.95

307.65

2.6

2.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

56435

370256

5.74

307.65

24.8

22.4

90.76

90.71

1.88

56159

366799

(3023103) Potassium [Moles/volume] in Serum or Plasma

53616

336382

2.62

307.65

18.0

17.3

3.94

3.96

mmol/l

38.17

52828

329090

(3021960) Folate [Moles/volume] in Serum or Plasma

18192

89575

1.58

307.65

1.7

20.48

20.04

nmol/l

3.25

16027

76813

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

28697

163618

1.42

307.65

6.3

7.4

1.21

mmol/l

1.27

25027

141615

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

51854

329666

1.91

307.65

5.0

4.7

1.45

1.46

mmol/l

3.99

49334

310029

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11418

43301

2.02

307.65

2.0

1.7

1.46

1.43

4.17

10304

38489

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

16903

86202

1.50

307.65

2.4

2.3

2.61

2.79

mg/l

23.13

14700

74796

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

42041

238529

1.81

307.65

3.7

3.2

42.72

45.67

u/l

9.87

40209

226050

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

55344

355215

3.45

307.65

12.3

11.6

26.89

26.62

u/l

1.39

54363

345966

(3021601) Nitrite [Presence] in Urine by Test strip

32120

181802

1.49

307.65

3.9

3.8

0.00

estimate

0.26

6763

37289

(3015736) pH of Urine

26602

146830

1.46

307.65

3.5

3.4

6.21

6.22

0.66

14602

82652

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

11475

44750

1.96

307.65

2.5

2.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21776

115993

1.47

307.65

3.3

31.42

33.21

u/l

2.81

20678

109736

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13441

64762

1.56

307.65

1.4

1.3

29.04

33.52

iu/ml

0.67

3795

19776

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

20286

107094

1.47

307.65

2.8

2.7

58.56

67.88

u/l

0.94

18821

99564

(3048689) Calprotectin [Mass/mass] in Stool

11051

46856

1.77

307.65

2.4

2.6

107.86

134.63

ug/g

14.76

8835

37478

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

28587

154046

1.56

307.65

2.6

2.5

3163.79

76.43

nmol/l

0.50

26552

141313

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

47956

264242

2.57

307.65

5.1

4.4

14.52

14.72

pmol/l

63.66

45367

244014

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

46280

286614

1.59

307.65

19.0

18.2

13.44

13.54

53.49

45841

282841

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

30978

174839

1.48

307.65

5.4

6.6

10.64

11.34

umol/l

18.80

29429

166555

(3031040) Bacteria [#/volume] in Urine by Automated count

37972

220626

1.55

307.65

5.1

4.5

1709.94

1719.23

e6/l

0.01

481

2992

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

43673

255283

1.76

307.65

7.6

8.3

74.82

78.34

u/l

61.77

41784

243040

(3006315) Basophils [#/volume] in Blood

31153

175815

1.48

307.65

6.0

6.6

0.04

e9/l

0.01

27067

152210

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

51074

316635

2.05

307.65

5.1

4.8

5.77

5.87

mmol/l

67.14

48210

294342

(3000963) Hemoglobin [Mass/volume] in Blood

56442

370400

5.77

307.65

25.0

22.7

136.19

135.85

g/l

7.20

56174

367007

(3010813) Leukocytes [#/volume] in Blood

56441

370364

5.77

307.65

24.9

22.6

6.71

6.70

e9/l

0.36

55690

362019

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

26715

142469

1.55

307.65

2.2

2.1

98.58

96.62

pmol/l

9.02

14387

76373

(3009261) Glucose [Presence] in Urine by Test strip

32521

185359

1.48

307.65

3.9

3.8

0.37

0.19

estimate

0.34

6567

36141

(3044889) 12 lead EKG panel

39160

227712

1.59

307.65

3.9

3.8

41.91

3095.77

1.50

430

(3023323) Follitropin [Units/volume] in Serum or Plasma

5329

18835

2.04

307.65

1.4

24.16

26.49

iu/l

5.51

4558

16091

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

6608

24297

1.99

307.65

2.4

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15028

75159

1.51

307.65

1.8

0.88

1.22

mg/l

46.15

11348

57979

(3026361) Erythrocytes [#/volume] in Blood

56437

370303

5.74

307.65

24.8

22.5

4.53

4.52

e12/l

1.75

55684

361990

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

50311

310397

1.98

307.65

6.0

5.9

37.85

38.83

mmol/mol

132.87

48019

292690

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

17883

83207

1.70

307.65

1.4

1.3

1.25

1.72

u/ml

7.31

5227

22928

(3001122) Ferritin [Mass/volume] in Serum or Plasma

33818

167191

1.96

307.65

3.5

3.1

96.11

117.68

ug/l

60.09

32159

157099

(3013115) Eosinophils [#/volume] in Blood

32081

181194

1.50

307.65

6.2

6.8

0.19

e9/l

0.57

28264

159289

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

52614

335291

2.03

307.65

5.7

5.4

2.77

2.75

mmol/l

2.72

50149

315597

(3035350) Ketones [Presence] in Urine by Test strip

32374

184029

1.49

307.65

3.9

3.8

3.92

3.76

estimate

0.06

6837

38008

(3001604) Monocytes [#/volume] in Blood

31112

175384

1.49

307.65

6.0

6.6

0.56

0.58

e9/l

24.98

27043

151878

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

53845

336271

2.83

307.65

16.2

14.9

20.28

23.67

mg/l

114.83

45280

274141

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

51594

319697

2.16

307.65

14.8

14.4

87.64

84.21

ml/min/173m2

256.60

48007

292591

(3035941) MCH [Entitic mass]

56438

370257

5.77

307.65

24.8

22.4

30.29

30.23

12.32

56166

366801

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

49537

313088

1.68

307.65

4.2

4.1

1.31

1.28

mmol/l

8.89

46737

292267

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

52068

331520

1.93

307.65

5.0

4.8

4.68

4.67

mmol/l

0.23

49715

313298

(3013826) Glucose [Moles/volume] in Serum or Plasma

33246

195870

1.40

306.05

4.9

5.0

6.42

6.66

mmol/l

75.01

31526

184109

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7368

32090

1.67

305.30

2.0

2.3

377.20

379.80

nmol/l

0.51

6831

29929

(3024561) Albumin [Mass/volume] in Serum or Plasma

26070

147439

1.40

304.30

4.4

5.2

36.75

35.96

g/l

102.61

24504

138576

(3022096) Basophils/Leukocytes in Blood

28151

161457

1.39

301.36

6.2

6.8

0.69

0.68

2.62

26507

151903

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

25731

145957

1.39

289.53

6.0

6.7

1.21

mmol/l

1.59

24055

135567

(3018095) Leukocytes [#/volume] in Urine

22473

124850

1.39

284.59

4.1

3.9

68.96

92.17

e6/l

5.05

15563

86259

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4252

16259

1.86

273.99

2.5

2.4

6162.88

6107.58

u/l

0.03

1558

6650

(3021589) Normoblasts [#/volume] in Blood

26581

152997

1.37

263.64

10.6

11.3

0.00

e9/l

4.99

21541

125204

(3014051) Protein [Presence] in Urine by Test strip

18472

100497

1.39

257.21

2.8

2.9

0.07

0.03

159

2116

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12335

62550

1.46

253.79

2.6

3.0

2.43

2.45

mmol/l

42.49

11034

56167

(40768797) Stomach Pathology biopsy report

9414

45245

1.52

252.45

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

3756

14179

1.88

250.97

1.6

1.7

303.82

303.90

mu/l

0.00

3347

12913

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

21647

121320

1.37

248.98

3.7

3.5

77.92

54.79

ng/l

0.56

12382

79798

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

24296

138784

1.36

246.74

3.7

0.70

0.49

estimate

0.39

5643

30735

(3018418) pH of Serum or Plasma

17959

97897

1.38

243.76

3.8

4.4

7.40

0.05

12338

69846

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

18250

99914

1.38

240.41

2.3

2.2

205.31

207.70

u/l

0.10

17376

94663

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

989

2035

3.39

240.35

2.1

2.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

21051

118083

1.36

237.19

3.4

1.56

2.05

e6/l

0.54

(3023511) Choriogonadotropin [Units/volume] in Urine

2326

7546

2.17

235.35

1.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

9183

44512

1.50

234.47

2.0

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

45851

290654

1.44

232.52

20.5

18.7

333.07

332.64

g/l

20.66

45671

289033

(3037522) Nuclear Ab [Titer] in Serum

10020

49970

1.46

220.29

1.4

482.21

537.54

titre

2.12

1884

10474

(40760892) CBC W Ordered Manual Differential panel - Blood

14973

80258

1.38

219.73

4.1

4.7

—

14.80

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4545

19027

1.70

213.47

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

18158

100827

1.35

211.55

3.1

3.2

0.30

0.25

estimate

0.22

5600

30098

(3002582) Erythrocytes [#/volume] in Urine

19157

107428

1.34

208.20

3.4

53.71

79.42

e6/l

3.02

14403

81381

(36304419) Bacteria [Presence] in Urine

16184

88472

1.36

207.65

3.2

50.58

147.64

estimate

0.52

361

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

12554

65937

1.40

205.32

1.7

29620461.16

37860859.76

pmol/l

0.79

10790

55282

(36660697) Celiac disease serology panel - Serum

6295

28900

1.56

203.75

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

15160

82310

1.36

201.89

3.9

3.7

0.62

0.25

1.55

760

(3017143) Hepatitis C virus Ab [Presence] in Serum

9137

45484

1.46

200.46

1.8

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6816

32000

1.53

199.16

2.7

2.6

36.62

50.18

u/l

2.67

5809

27195

(42870588) Differential panel, method unspecified - Blood

20418

116272

1.32

196.41

5.9

6.7

5.80

5.35

—

(3030467) Casts [#/volume] in Urine by Automated count

16739

92758

1.34

193.27

3.3

0.32

0.41

e6/l

8.22

12023

67354

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2826

10704

1.86

185.23

2.1

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

12288

65430

1.37

181.18

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5640

25891

1.55

181.15

1.2

126.39

144.92

u/ml

3.05

2185

9851

(3009214) Lutropin [Units/volume] in Serum or Plasma

2943

11447

1.81

177.06

1.4

8.92

9.92

u/l

3.89

2359

9310

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6095

28643

1.52

175.61

2.7

2.3

13.11

12.96

nmol/l

0.68

5558

26282

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2984

11739

1.79

172.83

2.1

1.8

39.38

40.60

nmol/l

1.71

2935

11515

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4973

22537

1.57

168.27

3.3

3.5

4.52

4.54

pmol/l

0.55

4464

20422

(3033658) Prothrombin time (PT) actual/Normal

15337

85231

1.33

168.27

4.1

4.2

92.67

91.05

13.51

14905

83339

(3000492) Spirometry study

7247

35564

1.46

168.22

1.5

—

18.61

—

(3019150) Specific gravity of Urine by Refractometry

14687

81160

1.33

167.38

4.0

3.9

1.02

1.17

kg/l

2.30

9390

53309

(3013139) Helicobacter pylori Ag [Presence] in Stool

5154

23639

1.55

165.28

1.2

—

(3025941) Bacteria identified in Stool by Culture

4335

19229

1.60

160.29

1.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

10755

57136

1.36

157.39

2.4

2.7

14.16

13.62

umol/l

0.85

10089

53359

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2300

8616

1.87

155.45

2.1

1.8

202.70

201.82

pmol/l

0.13

2192

8246

(3005322) IgE [Units/volume] in Serum or Plasma

5143

23899

1.53

154.87

1.3

217.18

239.50

u/ml

0.45

4794

22279

(4198724) Urine methamphetamine measurement

714

1583

3.13

154.32

3.0

2.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7764

39219

1.42

152.90

2.3

2.8

6.80

8.44

umol/l

11.26

6572

34324

(3022145) Colonoscopy Study observation

7676

38779

1.42

150.87

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

17396

99521

1.29

150.20

4.1

4.0

0.00

estimate

0.53

6521

34604

(40758558) Short blood count panel - Blood

17737

101919

1.29

147.26

5.7

6.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

9622

50893

1.36

142.91

1.8

1.7

1208.40

1154.60

nmol/l

6.30

7378

38919

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9976

53116

1.35

141.86

2.4

2.6

2.41

2.35

g/l

21.59

9227

49128

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

23638

141174

1.26

141.14

1.9

1.41

1.36

mmol/l

12.94

20535

120067

(3020961) Endomysium IgA Ab [Titer] in Serum

3871

17246

1.58

139.72

1.1

146.96

195.81

titre

0.49

499

(3000850) Epithelial cells [#/volume] in Urine

13195

73424

1.31

137.75

2.6

2.7

6.50

5.87

e6/l

3.73

11998

66800

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11316

61973

1.32

131.48

4.0

3.8

270.76

479.78

ng/l

5.47

7757

46020

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10682

58052

1.33

130.93

3.0

2.9

0.99

1.16

e6/l

2.03

5344

30425

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

3037

13052

1.64

126.63

1.4

1.3

229.81

222.55

miu/ml

0.49

1415

6104

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3061

13236

1.63

124.49

1.6

11.50

16.63

u/ml

6.04

756

3314

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

9811

53207

1.32

120.65

3.1

3.0

3.47

3.17

e6/l

1.31

4454

25458

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1391

4789

2.02

119.73

1.6

1.5

—

(3008898) HLA-B27 [Presence]

2981

12939

1.62

119.26

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

15208

87755

1.26

114.97

2.4

2.7

329.43

338.41

umol/l

24.56

13693

78345

(3004716) Salmonella sp identified in Stool by Organism specific culture

3835

17964

1.50

109.39

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8989

48913

1.31

106.23

2.4

2.7

23.40

22.74

4.51

8366

45497

(3024666) Lithium [Moles/volume] in Serum or Plasma

704

1921

2.54

104.52

13.0

13.2

0.59

0.62

mmol/l

2.71

660

1770

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3768

17761

1.49

104.07

1.1

10.56

6.57

u/ml

0.19

223

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1602

6091

1.83

102.84

1.5

0.37

0.42

nmol/l

1.05

1250

4728

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

582

1472

2.74

100.15

2.3

2.0

167.76

118.81

umol/l

2.07

302

737

(21494755) Public health laboratory ask at order entry panel

7100

37691

1.34

98.97

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2155

9029

1.67

98.66

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9918

55156

1.29

98.62

2.9

3.7

0.82

mmol/l

1.26

9257

52084

(3014765) Yersinia sp identified in Stool by Organism specific culture

2166

9090

1.67

98.55

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2165

9116

1.66

97.24

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4545

22511

1.42

96.70

1.3

44.35

52.11

au/ml

1.62

254

1379

(3042517) Benzodiazepines panel - Urine

252

366

4.75

96.58

3.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

26076

161298

1.21

96.51

2.7

2.8

—

estimate

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4856

24373

1.41

95.79

2.4

19.70

21.09

au/ml

0.64

607

2817

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1458

5538

1.83

93.85

1.4

1.3

23.57

26.38

u/l

2.48

1179

4565

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2270

9771

1.62

93.46

1.4

297.80

272.03

ug/g

4.81

1261

5649

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2834

12892

1.54

92.17

1.6

1.7

3.66

4.33

mg/l

3.37

2228

9275

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1229

4459

1.92

91.07

1.6

1.7

372.23

382.32

mu/l

0.23

1006

3627

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

2010

8501

1.65

88.64

1.1

1.97

2.23

u/ml

0.57

1037

4550

(3032080) INR in Blood by Coagulation assay

24005

148345

1.20

85.67

12.3

13.5

1.18

1.22

inr

30.85

19851

123777

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2747

12631

1.52

84.89

1.5

1.4

—

(3000494) Fungus identified in Specimen by Culture

7567

41367

1.30

84.28

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2160

9431

1.60

83.77

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1249

4687

1.85

83.50

5.9

5.5

366.62

367.82

umol/l

0.10

1108

4116

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1698

6993

1.69

82.76

1.1

1.84

1.85

u/ml

0.01

827

3552

(3026782) Osmolality of Urine

10926

62595

1.25

82.73

2.7

2.9

519.37

532.26

mosm/kgh2o

6.62

9522

55051

(3007853) Bacteria identified in Skin by Aerobe culture

7389

40409

1.30

81.84

1.7

1.8

—

(3017732) Neutrophils [#/volume] in Blood

7914

43719

1.29

81.01

2.8

3.2

4.30

4.49

e9/l

1.50

6919

38134

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

4981

25805

1.36

80.30

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1466

5844

1.75

80.29

1.1

4.81

4.80

u/ml

0.00

664

2684

(3009508) Creatinine [Moles/volume] in Urine

18854

114642

1.20

78.06

3.3

3.5

7.84

7.72

mmol/l

2.49

16335

98153

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1526

6210

1.71

77.67

1.1

3.76

4.09

u/ml

0.31

743

3173

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2104

9307

1.58

77.16

1.2

4.10

3.99

0.24

356

1370

(3003888) Timothy IgE Ab [Units/volume] in Serum

1751

7421

1.64

76.49

1.1

5.22

5.37

u/ml

0.14

933

3972

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2905

13815

1.47

76.05

1.3

0.62

0.87

u/ml

0.79

259

1058

(3020191) Ethanol [Moles/volume] in Serum or Plasma

844

2864

2.04

75.54

1.7

1.5

1.44

1.28

promille

2.13

642

2304

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1501

6163

1.69

73.94

1.1

17.17

15.31

au/ml

0.44

428

1679

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1671

7094

1.64

72.49

1.1

0.92

1.12

u/ml

0.67

701

3169

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2123

9645

1.53

69.11

1.1

4.13

5.61

eliau/ml

0.78

302

1252

(3014111) Lactate [Moles/volume] in Serum or Plasma

5474

29392

1.31

68.52

7.2

8.1

1.34

1.33

mmol/l

0.20

5369

28855

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1296

5220

1.73

68.42

1.1

0.37

0.35

u/ml

0.04

373

1630

(3003740) Influenza virus B Ag [Presence] in Specimen

1668

7187

1.62

68.17

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1667

7195

1.61

67.66

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2496

11799

1.48

67.18

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7073

39584

1.26

63.63

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6702

37274

1.27

63.53

1.9

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

7690

43541

1.25

62.43

1.9

3.48

3.51

ratio

1.24

5631

33017

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7183

40415

1.26

61.54

1.7

1.8

—

6.44

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9302

54026

1.22

59.12

1.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1924

8854

1.51

58.92

1.3

475.29

542.76

mg/l

4.65

1847

8490

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3669

19043

1.35

57.59

3.9

4.3

24.28

24.22

mmol/l

0.62

3610

18826

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1735

7856

1.54

57.26

1.3

1.5

1105.32

2207.31

e6/l

0.91

1342

6188

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1714

7763

1.54

56.50

1.3

1.4

36.18

32.47

e6/l

0.14

1244

5750

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2646

13057

1.41

56.49

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2637

13021

1.41

56.08

1.2

1.3

—

(3045414) Leukocytes [Presence] in Urine

5837

32410

1.27

55.52

2.0

2.1

0.02

0.03

estimate

0.64

1338

6689

(40761536) Microorganisms panel - Urine sediment

5037

27482

1.29

55.18

3.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1720

7852

1.52

54.67

1.2

1.3

3.68

3.73

mmol/l

1.15

1637

7433

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4494

24297

1.30

52.69

1.6

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

5857

32730

1.26

52.58

1.6

3.45

3.49

mmol/l

1.55

3892

22031

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1204

5103

1.64

52.56

1.1

2.71

2.88

eliau/ml

0.19

613

2455

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13777

83677

1.18

52.49

2.3

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2063

9887

1.45

51.58

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2048

9901

1.44

48.87

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7460

43120

1.22

48.69

4.9

6.5

1.03

1.04

mmol/l

3.74

6916

40266

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1062

4475

1.65

47.46

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1316

5934

1.54

44.27

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

637

2379

1.85

43.41

1.7

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

1855

9017

1.43

42.95

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1137

5008

1.57

42.42

1.1

2.50

2.82

0.62

233

848

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2030

10085

1.40

41.55

2.0

5.06

18.23

iu/l

1.59

838

4190

(3022621) pH of Urine by Test strip

4902

27582

1.24

40.81

2.4

2.5

6.13

6.09

2.56

2987

18049

(3005719) IgG [Mass/volume] in Serum or Plasma

4843

27222

1.25

40.69

2.4

2.9

10.48

10.60

g/l

1.25

4421

25253

(3042936) Bacteria identified in Isolate by Culture

8064

47758

1.19

39.81

2.0

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1137

5110

1.54

38.85

2.5

13.09

13.16

1.38

1128

5047

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3505

19064

1.28

38.80

1.8

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5521

31657

1.22

38.33

2.2

2.4

0.22

0.21

g/l

19.77

5152

29606

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

578

2180

1.83

38.25

1.3

5.34

5.33

umol/l

0.03

514

1947

(3002256) Pathology report gross observation

7589

44853

1.19

38.20

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

633

2462

1.78

37.89

1.2

—

(3025130) Human papilloma virus identified in Specimen

1300

6077

1.48

36.91

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

14549

90644

1.14

36.36

3.0

3.1

1048.56

1275.68

ng/l

9.22

12060

77404

(3026389) Candida sp identified in Specimen by Organism specific culture

1146

5237

1.52

36.30

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

3071

16665

1.28

34.53

2.0

2.1

0.03

0.13

estimate

0.89

1142

5299

(3007463) Buprenorphine [Presence] in Urine

129

4.75

34.49

9.0

7.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2123

10959

1.35

34.23

1.3

25.33

39.59

u/ml

1.62

103

598

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

4647

26473

1.23

34.17

2.6

2.7

73.08

67.77

ml/min/173m2

16.54

2078

10886

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1650

8188

1.40

33.99

1.2

1.3

38.56

46.15

u/ml

0.86

136

763

(3023368) Bacteria identified in Blood by Culture

14299

89303

1.14

33.93

4.2

4.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2824

15195

1.29

33.91

1.8

1.9

6.72

7.93

iu/ml

0.95

667

3545

(3028026) IgM [Mass/volume] in Serum or Plasma

3778

21096

1.25

33.42

1.8

2.0

1.31

1.30

g/l

0.15

3490

19500

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

679

2795

1.68

33.32

1.8

2.2

20.05

18.99

nmol/l

2.00

641

2656

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8303

49992

1.17

32.92

1.9

2.2

29.41

29.54

1.32

8076

48650

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

603

2411

1.73

32.90

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

643

2621

1.70

32.73

1.1

7.00

8.32

iu/ml

0.70

180

719

(44813793) Dust mix specific IgE antibody measurement

633

2571

1.70

32.65

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

596

2387

1.73

32.34

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

373

1286

2.00

32.31

2.5

2.6

135.17

151.49

nmol/l

2.48

336

1124

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

498

1908

1.80

31.44

1.7

1.5

1807041.73

1949720.91

iu/ml

0.10

132

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

465

1744

1.84

31.44

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

16658

105402

1.12

31.41

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6113

36101

1.19

30.50

6.3

6.6

—

(3023410) Appearance of Cerebral spinal fluid

798

3509

1.57

30.12

1.4

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

4694

27117

1.21

29.83

3.2

3.4

4.62

4.59

kpa

0.41

4549

26430

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3862

21897

1.23

29.58

7.8

8.5

24.87

24.76

mmol/l

1.03

3838

21731

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

252

773

2.25

29.43

2.0

2.1

14.78

16.88

umol/l

2.19

252

773

(3016650) Hepatitis A virus Ab [Presence] in Serum

1281

6241

1.42

29.35

1.1

—

(3013512) EKG study

17031

108232

1.12

29.24

3.5

0.65

0.75

0.64

244

(44806420) Estimation of glomerular filtration rate

860

3902

1.52

28.27

2.4

2.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3892

22186

1.22

28.26

1.5

1.6

1014.38

1012.34

mu/l

0.04

3281

18896

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5545

32677

1.19

28.23

3.8

4.1

5.87

5.82

kpa

3.26

5394

31906

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1269

6218

1.41

28.17

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

805

3622

1.54

27.51

1.2

46.50

28.00

nmol/l

1.56

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

159

405

2.71

27.45

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

6125

36499

1.17

27.23

2.4

2.6

1.79

1.77

0.43

5449

32729

(3003181) Sodium [Moles/volume] in Urine

1177

5729

1.42

27.14

1.5

1.4

60.51

62.06

mmol/l

0.60

935

4526

(3024928) Oxygen saturation in Venous blood

1600

8209

1.35

26.88

3.1

3.4

61.08

62.79

2.35

1528

7955

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1946

10276

1.31

26.84

1.3

8.06

8.71

u/ml

0.16

267

1474

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

612

2604

1.62

26.55

1.1

17.83

19.44

u/ml

0.51

292

1040

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1226

6035

1.41

26.54

1.3

1.4

3.13

3.59

ug/l

1.67

1124

5421

(4034850) Laboratory test

1861

9784

1.32

26.49

9.4

9.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

1948

10311

1.31

26.41

1.2

1.3

102.01

120.46

titre

0.69

189

1000

(1761482) Bacteria [#/volume] in Urine by Culture

722

7510

0.66

26.27

3.9

4.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2118

11374

1.29

25.78

1.7

1.8

1.20

1.19

g/l

0.36

2037

10887

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2066

11060

1.30

25.76

1.7

1.8

0.23

g/l

0.54

1985

10548

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3370

19111

1.23

25.68

9.4

10.3

24.35

24.27

mmol/l

0.71

3287

18718

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1939

10302

1.31

25.58

1.3

4.34

6.62

u/ml

1.07

158

974

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1247

6217

1.39

25.08

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

137

339

2.79

25.00

1.2

1.4

2.46

2.38

mmol/l

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1246

6216

1.39

24.96

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3683

21136

1.21

24.92

9.4

10.4

93.91

94.02

0.52

3667

21075

(3002032) Base excess in Venous blood by calculation

5362

31831

1.18

24.85

3.8

4.1

1.71

1.78

mmol/l

0.61

4742

28028

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3668

21061

1.21

24.68

9.4

10.3

1.40

1.32

4.10

3656

20939

(3012544) pH of Venous blood

5553

33110

1.17

24.34

3.8

4.1

7.38

1.32

2910

19082

(3034770) Mitochondria Ab [Titer] in Serum

1897

10119

1.30

24.31

1.2

1.3

784.17

957.92

titre

0.48

279

(3015076) Soybean IgE Ab [Units/volume] in Serum

527

2210

1.65

24.27

1.0

0.48

0.91

u/ml

0.72

109

551

(3034274) Bile acid [Moles/volume] in Serum --fasting

1153

5713

1.40

24.07

1.9

2.2

5.42

6.85

umol/l

2.69

853

4188

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

2735

15282

1.24

23.92

1.1

1.52

1.51

g/l

0.41

2729

15273

(3013005) Retinol [Moles/volume] in Serum or Plasma

397

1546

1.77

23.90

1.5

1.9

1.98

1.95

umol/l

0.35

358

1410

(3014599) Egg white IgE Ab [Units/volume] in Serum

563

2411

1.61

23.86

1.0

1.1

2.40

2.05

u/ml

0.16

135

609

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1005

4869

1.43

23.83

1.3

0.60

1.75

nmol/l

1.58

974

4703

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4555

26774

1.19

23.70

2.3

2.5

0.37

0.40

e6/l

0.50

4323

25559

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1015

4934

1.42

23.63

1.3

0.22

0.25

nmol/l

0.27

304

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4348

25461

1.19

23.63

3.4

4.0

1.23

mmol/l

1.40

3758

22015

(3023183) Ammonium ion [Moles/volume] in Plasma

1366

6979

1.36

23.63

2.4

2.8

32.23

34.13

umol/l

2.23

1228

6333

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2146

11729

1.27

22.72

2.0

2.3

426.49

542.81

ug/l

1.29

1996

11058

(3017315) Amylase [Enzymatic activity/volume] in Urine

421

1693

1.72

22.71

1.4

1.2

264.00

335.18

u/l

0.90

389

1587

(3019977) pH of Arterial blood

6190

37426

1.16

22.50

7.6

8.1

7.42

0.23

3204

20336

(3025159) Blasts/Leukocytes in Blood

5003

29767

1.17

22.44

4.3

4.8

0.19

0.29

0.62

1045

7603

(3016244) Insulin [Units/volume] in Serum or Plasma

539

2327

1.60

22.15

2.7

3.2

26.29

26.38

mu/l

0.02

502

2190

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3540

20469

1.20

22.09

9.6

10.6

0.63

0.64

0.79

3530

20364

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

317

1181

1.85

22.08

1.4

14.07

14.93

pmol/l

2.10

267

998

(3036180) Methadone [Presence] in Urine

5.44

22.02

2.1

3.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1199

6073

1.37

21.94

1.6

0.70

0.77

g/l

1.81

939

4734

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

2583

14482

1.24

21.89

1.1

0.64

0.63

ratio

0.45

255

1670

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

802

3791

1.46

21.73

1.1

22.50

22.46

au/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

589

2613

1.56

21.57

1.4

1.3

229.50

176.83

pmol/l

0.59

589

2613

(3020891) Body temperature

2609

14668

1.23

21.55

4.5

4.6

36.93

36.91

°c

1.37

2585

14537

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4239

24971

1.18

21.44

3.4

4.1

80.87

89.20

ng/l

8.36

3714

21786

(3027801) Oxygen [Partial pressure] in Arterial blood

6162

37370

1.15

21.40

7.5

8.1

12.43

12.69

kpa

3.17

5945

35968

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6164

37387

1.15

21.37

7.5

8.1

5.10

5.08

kpa

0.87

5949

35998

(3019420) Tryptase [Mass/volume] in Serum or Plasma

490

2088

1.62

21.26

1.4

1.6

6.56

8.71

ug/l

2.37

453

1908

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

347

1350

1.77

21.04

1.4

72.88

73.17

0.14

329

1293

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2782

15787

1.22

21.02

1.1

1.2

0.89

g/l

0.06

2772

15745

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

909

4431

1.42

20.90

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

566

2514

1.55

20.64

1.0

1.1

2.64

1.59

u/ml

0.36

170

817

(3008295) Osmolality of Serum or Plasma

724

3389

1.48

20.64

1.6

1.4

278.51

279.12

mosm/kgh2o

0.29

526

2635

(3038515) Glucose [Moles/volume] in Venous blood

635

6447

0.67

20.54

3.3

7.08

7.51

mmol/l

3.06

610

6313

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

777

3700

1.45

20.30

1.1

87.57

67.91

au/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

500

2167

1.59

20.27

1.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

340

1331

1.76

20.21

1.4

503.22

671.24

mu/l

0.98

322

1274

(3003396) Base excess in Arterial blood by calculation

6091

37140

1.14

19.46

7.5

8.0

0.80

0.93

mmol/l

1.70

5120

30645

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

218

748

2.01

19.40

2.1

2.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

939

4673

1.39

19.21

1.9

3397.21

3882.67

titre

0.13

195

(3028192) IgG subclass 2 [Mass/volume] in Serum

778

3751

1.43

19.06

1.3

1.4

3.02

2.94

g/l

0.60

561

2707

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1716

9334

1.27

18.94

2.0

2.3

0.03

0.02

g/l

0.16

1529

8448

(3024139) IgG subclass 3 [Mass/volume] in Serum

775

3752

1.43

18.58

1.3

1.4

0.37

0.41

g/l

3.19

560

2709

(3029634) Reagin Ab [Titer] in Serum by VDRL

1083

5545

1.35

18.57

2.5

2.2

8.56

8.22

titre

0.03

159

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5268

31910

1.15

18.48

3.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

458

1989

1.59

18.47

1.4

1.5

24.42

23.07

umol/l

0.42

429

1853

(3027135) IgG subclass 1 [Mass/volume] in Serum

775

3758

1.42

18.42

1.3

1.4

6.48

6.76

g/l

1.51

560

2710

(3016502) Oxygen saturation in Arterial blood

5470

33232

1.15

18.38

7.8

8.5

95.75

95.74

0.00

5326

32060

(4062490) Immunoglobulin typing, IgG

762

3689

1.43

18.28

1.3

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2622

15005

1.21

18.21

2.1

40.78

39.76

u/l

1.77

2362

13531

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

402

1700

1.63

18.08

1.2

8.64

9.84

mm/h

1.62

402

1700

(3002079) Sodium [Moles/time] in 24 hour Urine

387

1621

1.65

18.07

1.4

1.2

155.37

160.56

mmol/24h

0.56

387

1621

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

646

3038

1.47

18.07

1.2

37.01

44.71

mg/l

3.07

537

2583

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1640

8924

1.27

18.06

2.0

2.3

0.00

g/l

0.20

1424

7860

(3035637) Corticotropin [Mass/volume] in Plasma

905

4527

1.38

17.98

1.5

1.6

27.50

34.05

ng/l

2.01

900

4517

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1937

10760

1.25

17.89

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

604

2810

1.48

17.84

1.2

1.3

2.41

1.98

u/ml

0.35

340

1647

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

342

1392

1.69

17.80

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1588

8623

1.27

17.79

1.3

5.54

5.11

u/ml

0.06

577

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

397

1683

1.63

17.69

1.6

15.99

5.52

nmol/l

0.37

329

1396

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1317

6988

1.30

17.65

1.8

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

312

1242

1.73

17.59

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

844

4195

1.39

17.44

1.3

0.21

0.26

nmol/l

0.41

658

3270

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.37

17.35

1.7

1.1

2.09

2.04

g/l

0.09

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

455

2004

1.57

17.32

1.1

5.39

5.65

nmol/l

0.04

371

(4024509) Urine culture

2644

15219

1.21

17.29

2.0

1.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

292

1147

1.76

17.25

2.1

2.5

1.10

1.09

ug/l

0.02

274

1084

(3052851) Hemolysis interference index of Serum or Plasma

1648

9029

1.26

17.17

2.8

3.2

2.19

2.15

index

0.06

841

4575

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

155

490

2.18

17.11

1.1

1.0

9.50

8.83

u/ml

0.09

155

490

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2925

17026

1.19

16.93

3.2

3.1

1.41

1.26

8.45

2916

16952

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

622

2946

1.46

16.81

1.1

246.16

269.97

mg/l

1.26

547

2627

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1533

8353

1.27

16.72

2.0

2.4

0.00

g/l

-0.00

1423

7841

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2901

16896

1.19

16.69

3.2

3.1

0.61

0.62

1.82

2894

16846

(43055514) Macroprolactin [Presence] in Serum or Plasma

262

1008

1.79

16.62

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

272

1059

1.77

16.59

1.2

—

(3017509) Phencyclidine [Presence] in Urine

141

435

2.23

16.52

2.2

1.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

150

476

2.17

16.43

1.0

87.85

81.15

ug/l

1.03

119

374

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

252

964

1.80

16.30

1.4

1.3

124.33

133.49

nmol/l

0.28

191

700

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4162

25031

1.16

16.06

2.5

2.3

5.83

7.58

ug/l

7.08

3596

22006

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12020

88814

0.91

16.00

5.1

5.0

2.10

2.82

ug/l

3.90

11033

81087

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1396

7567

1.28

15.91

1.2

1.3

246.90

257.90

u/ml

0.83

880

4855

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3204

18907

1.18

15.80

2.5

3.6

37.92

54.86

u/ml

2.56

3104

18288

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

586

2779

1.46

15.78

1.1

—

(40768443) Skin Pathology biopsy report

2661

15460

1.19

15.74

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

386

1683

1.58

15.41

1.8

2.05

3.00

u/ml

0.76

108

476

(3050129) First trimester maternal screen panel - Serum or Plasma

2512

14557

1.20

15.29

1.4

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

604

2899

1.44

15.28

1.2

114.07

111.18

pmol/l

0.51

604

2899

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

265

1053

1.74

15.13

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1236

6644

1.29

15.08

2.6

3.5

7.49

9.20

pmol/l

8.35

1236

6638

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1471

8079

1.26

15.06

1.2

1.3

47.27

43.66

u/ml

0.15

131

(3019225) pH of Specimen

4913

30026

1.14

15.00

3.6

4.2

7.36

0.00

3427

21681

(3023520) Reticulocytes [#/volume] in Blood

4593

27954

1.14

14.93

2.4

2.7

71.19

70.00

e9/l

1.23

3214

20558

(3002179) Metamyelocytes/Leukocytes in Blood

4812

29390

1.14

14.83

3.9

4.4

0.68

0.70

0.26

1206

8779

(4027681) Cerebrospinal fluid IgG ratio and IgG index

494

2294

1.49

14.83

1.3

1.2

0.69

0.65

ratio

0.11

276

1322

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

170

594

1.97

14.54

1.7

1.6

1.45

1.15

nmol/l

—

(3036489) Thrombin time

2350

13600

1.20

14.53

1.9

2.2

20.39

21.02

6.70

2024

11963

(3020911) Cortisol [Moles/time] in 24 hour Urine

301

1257

1.65

14.35

1.5

1.4

181.90

160.93

nmol/24h

0.08

301

1257

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5102

31343

1.13

14.35

8.3

8.9

123.32

121.39

g/l

9.12

5009

30602

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

683

3390

1.39

14.34

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

201

747

1.85

14.33

1.1

28.24

29.81

iu/ml

0.15

201

747

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1601

8939

1.24

14.19

1.3

30.23

14.16

u/ml

0.53

108

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1924

10963

1.21

14.02

2.1

2.5

0.63

0.76

g/l

1.03

1667

9483

(1616796) Gas panel - Central venous blood

1336

7344

1.26

13.62

3.1

3.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1490

8294

1.24

13.60

1.4

1.5

59.42

60.19

ug/l

0.29

1490

8294

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.03

13.31

1.8

1.5

226.57

281.96

nmol/l

0.25

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

597

2935

1.40

13.30

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

335

1465

1.58

13.30

1.5

1.9

28.82

28.77

umol/l

0.03

304

1376

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

288

1217

1.63

13.16

1.2

108.52

110.82

0.71

258

1098

(3005082) Progesterone [Moles/volume] in Serum or Plasma

502

2399

1.44

13.09

1.4

1.5

34.52

34.13

nmol/l

0.09

453

2225

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

136

457

2.05

13.00

1.1

—

(3012501) Base excess in Blood by calculation

1228

6723

1.26

12.98

3.4

3.9

2.32

2.51

mmol/l

1.77

820

4512

(3013290) Carbon dioxide [Partial pressure] in Blood

1228

6725

1.26

12.95

3.4

3.9

5.02

5.00

kpa

0.35

1205

6565

(3021440) Promyelocytes/Leukocytes in Blood

4797

29564

1.13

12.76

4.1

4.6

0.13

0.12

0.41

1029

7940

(3027315) Oxygen [Partial pressure] in Blood

1231

6771

1.26

12.52

3.4

3.9

8.88

8.72

kpa

2.48

1208

6610

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

289

1244

1.60

12.30

1.0

0.37

0.67

u/ml

1.57

282

1220

(3011985) Renin [Units/volume] in Plasma

959

5132

1.29

12.21

1.6

70.82

63.07

mu/l

0.40

873

4629

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

301

1311

1.58

12.20

1.2

0.30

g/l

0.31

239

1047

(3041806) Other cells [#/volume] in Blood by Manual count

350

1579

1.53

12.16

1.6

1.4

0.50

0.52

e9/l

0.75

350

1579

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

253

1057

1.65

12.14

1.2

1.3

12.43

22.22

1.37

188

(3001556) Androgen free Index in Serum or Plasma

115

373

2.12

12.08

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

4982

30887

1.12

11.97

4.1

4.6

0.99

0.94

0.41

1214

9233

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

424

2001

1.46

11.86

1.5

6.06

6.04

u/l

0.01

369

1708

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2072

12080

1.19

11.85

2.0

2.4

2.85

2.89

g/l

1.28

1879

11013

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

404

1889

1.48

11.85

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3499

21270

1.14

11.56

3.3

3.7

5.12

5.14

kpa

0.70

3353

20294

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1010

5482

1.27

11.53

1.1

119.80

117.57

1.48

905

5019

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1433

8090

1.22

11.53

1.4

87.24

140.98

pmol/l

6.44

1390

7891

(3010838) Calcium [Moles/time] in 24 hour Urine

1137

6260

1.26

11.51

1.9

5.29

5.15

mmol/24h

0.70

1013

5644

(3010421) pH of Blood

1780

10274

1.20

11.40

3.2

3.5

7.41

0.61

1757

10126

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

881

4716

1.29

11.24

1.4

344.82

372.59

pmol/l

0.37

778

4063

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

370

1720

1.48

11.20

1.2

1.3

68.50

64.18

0.30

218

(3009343) pH of Capillary blood

3398

20662

1.14

11.18

3.3

3.7

7.41

7.42

1.34

2861

17182

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2990

18031

1.15

11.11

3.1

3.6

1.55

1.74

mmol/l

2.28

2159

13199

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

161

607

1.83

11.11

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

558

2800

1.38

11.10

1.2

1.3

1.90

2.12

mmol/l

4.72

511

2601

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1096

6050

1.25

10.88

1.3

4.51

3.55

u/ml

0.60

429

2313

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

250

2.31

10.87

1.2

44.93

48.73

mg/l

0.41

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

184

2.55

10.76

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

807

4298

1.30

10.73

1.3

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

125

439

1.96

10.69

1.2

61.23

63.67

ug/l

0.76

125

439

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

143

527

1.87

10.62

1.2

—

(3020650) Glucose [Presence] in Urine

277

1225

1.56

10.60

1.6

0.02

0.05

estimate

0.91

277

1225

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1834

10709

1.18

10.35

2.4

2.7

178.72

189.43

5.90

1721

10206

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

723

3814

1.31

10.34

2.0

25.43

25.23

mg/l

0.04

268

1422

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

276

1229

1.55

10.27

1.2

113.40

108.35

1.26

243

1125

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

819

4402

1.28

10.18

1.3

1.4

—

(3045716) Anion gap in Serum or Plasma by calculation

659

3440

1.32

10.17

2.8

3.1

10.18

10.83

mmol/l

4.55

651

3396

(3024522) Salmonella sp identified in Specimen by Organism specific culture

804

4312

1.29

10.16

1.3

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

333

1549

1.48

10.11

1.9

2.6

20.88

146.65

ug/l

1.90

318

1482

(3022806) Fractional oxyhemoglobin in Capillary blood

725

3839

1.30

10.10

1.8

90.11

0.00

715

3776

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1643

9527

1.19

10.05

2.0

2.2

10.98

11.41

mg/l

1.45

1528

8967

(3006922) Hepatitis E virus Ab [Presence] in Serum

578

2965

1.35

10.05

1.1

—

(4195642) Thrombophilia screening test

990

5455

1.25

10.02

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1054

5869

1.24

9.73

1.3

4.69

3.90

u/ml

0.53

491

2793

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

374

1794

1.44

9.71

2.0

1.9

137.54

147.88

1.92

356

1701

(3004775) Volume in Urine collected for unspecified duration

224

2398

0.64

9.71

2.0

2.4

686.25

671.19

0.20

152

1684

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2106

12512

1.16

9.63

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

1712

10002

1.18

9.63

3.9

4.2

1.36

1.38

mmol/l

0.27

1691

9805

(3005988) Vibrio sp identified in Specimen by Organism specific culture

766

4113

1.29

9.62

1.3

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

405

1976

1.41

9.59

1.0

264.09

348.11

ng/l

3.84

310

1452

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

407

1988

1.41

9.58

1.0

33.31

42.31

ng/l

4.86

308

1432

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

267

1200

1.53

9.57

1.1

96.42

90.27

2.60

118

575

(3016038) Potassium [Moles/volume] in Urine

430

2123

1.40

9.52

1.2

31.77

33.83

mmol/l

1.18

377

1865

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

764

4108

1.28

9.50

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9648

70604

0.93

9.37

4.2

4.1

21.68

22.00

1.06

3901

32021

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

405

1985

1.41

9.36

1.0

829.11

748.49

ng/l

2.41

288

1415

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

496

2516

1.36

9.32

1.1

—

0.25

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

437

2172

1.39

9.31

2.0

174.79

928.05

pmol/l

1.38

313

(3004616) Nuclear Ab [Presence] in Serum

819

4454

1.27

9.31

1.3

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.10

9.28

1.7

1.5

198.83

238.43

nmol/l

0.23

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

608

3182

1.32

9.27

4.4

5.4

115.17

104.03

u/ml

0.14

174

1130

(3025468) Yersinia sp identified in Specimen by Organism specific culture

760

4099

1.28

9.24

1.3

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

355

1705

1.44

9.19

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1023

5719

1.24

9.14

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

904

7709

0.80

9.12

3.0

3.1

1.51

1.55

mmol/l

0.50

871

7540

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

335

2.01

9.11

1.1

1.2

2.19

1.72

iu/ml

1.79

173

(3028679) Herpes simplex virus Ab [Presence] in Serum

441

2204

1.38

9.10

1.1

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

923

5110

1.25

9.02

1.2

13.39

17.87

u/ml

0.33

217

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

260

1178

1.52

9.01

1.1

100.86

90.32

3.88

116

573

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

792

6794

0.80

8.48

2.7

3.6

393.60

891.19

u/ml

1.67

707

6167

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1943

11593

1.16

8.45

2.0

2.4

96.24

93.68

5.65

1845

11175

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1850

11008

1.16

8.35

1.9

2.3

9.94

10.15

g/l

1.49

1637

9846

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

453

2312

1.35

8.25

2.7

3.5

81.43

152.17

nmol/l

5.94

443

2272

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1160

6642

1.21

8.23

1.7

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2049

12303

1.15

8.18

1.4

1.5

61.74

62.52

ug/l

0.29

1682

10319

(3043409) Potassium [Moles/volume] in Arterial blood

1440

8412

1.18

8.18

4.2

4.5

3.84

3.87

mmol/l

2.16

1435

8340

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1942

11620

1.16

8.14

1.4

1.5

1.16

1.17

ratio

0.18

1100

7002

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1947

11655

1.15

8.11

1.4

1.5

0.99

0.94

ratio

3.09

1105

7039

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1947

11655

1.15

8.11

1.4

1.5

1.18

ratio

0.00

1109

7106

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1634

9659

1.17

8.04

1.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

281

2.03

7.98

1.6

1.29

1.32

mg/l

0.02

166

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

281

2.03

7.98

1.6

2.36

2.71

mg/l

0.17

198

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

281

2.03

7.98

1.6

2.04

2.52

mg/l

0.41

195

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

281

2.03

7.98

1.6

3.94

3.91

mg/l

0.01

173

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

281

2.03

7.98

1.6

2.37

1.94

mg/l

0.26

181

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

281

2.03

7.98

1.6

0.71

0.90

mg/l

0.31

186

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

281

2.03

7.98

1.6

2.12

2.21

mg/l

0.05

206

(3027231) Wheat IgE Ab [Units/volume] in Serum

181

778

1.60

7.96

1.1

4.62

1.20

u/ml

0.48

153

673

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

272

2.05

7.96

1.1

1.2

0.56

0.58

iu/ml

0.04

131

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

282

2.03

7.91

1.6

1.97

1.64

mg/l

0.21

172

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

282

2.03

7.91

1.6

1.64

1.93

mg/l

0.27

206

(3005011) Chlamydia sp Ab [Titer] in Serum

113

429

1.81

7.79

1.8

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1892

11341

1.15

7.76

2.7

2.9

24.56

24.70

mmol/l

0.95

1857

11134

(3011841) English Walnut IgE Ab [Units/volume] in Serum

352

1.90

7.69

1.0

1.1

0.47

1.73

u/ml

1.35

268

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

290

1.99

7.68

1.6

1.78

1.71

mg/l

0.04

187

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2115

12788

1.14

7.66

2.0

2.3

4.24

4.23

g/l

0.29

1923

11733

(3028271) Lactate [Moles/volume] in Capillary blood

894

5026

1.23

7.66

1.9

1.8

1.75

1.73

mmol/l

0.21

867

4890

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

132

528

1.72

7.64

1.4

0.26

nmol/l

0.04

386

(3039162) Centromere protein B Ab [Units/volume] in Serum

828

4619

1.24

7.64

1.2

1.3

54.55

53.75

u/ml

0.03

274

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

758

4188

1.25

7.63

1.1

99.78

96.49

2.81

699

3958

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2117

12806

1.14

7.62

2.0

2.3

7.24

7.37

g/l

3.19

1925

11737

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2017

12165

1.15

7.59

1.6

8.66

5.70

iu/ml

0.14

353

2191

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2110

12768

1.14

7.56

2.0

2.3

3.74

3.71

g/l

0.36

1920

11710

(3001186) Copper [Moles/volume] in Serum or Plasma

215

979

1.51

7.39

1.2

1.3

16.66

16.61

umol/l

0.05

183

846

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

478

2506

1.32

7.32

1.1

1.2

1.21

2.02

0.40

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1899

11437

1.15

7.31

1.4

1.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

326

1.90

7.20

1.0

0.16

0.87

u/ml

1.27

232

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2379

14564

1.13

7.14

1.4

1.6

9.97

14.58

iu/ml

0.99

414

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

716

3964

1.25

7.11

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

284

1379

1.42

7.06

1.8

1.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1868

11268

1.15

7.04

3.3

3.9

24.68

24.82

mmol/l

1.41

1750

10388

(3051101) Glucose [Moles/volume] in Cord blood

506

0.35

7.04

5.9

5.5

8.30

8.53

mmol/l

0.20

506

(3020630) Protein [Mass/volume] in Serum or Plasma

4196

26508

1.10

7.00

2.1

2.7

66.80

66.45

g/l

2.41

3838

24442

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

251

1194

1.45

6.98

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

141

591

1.64

6.92

1.2

1.5

5.44

5.85

nmol/l

0.68

132

570

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1382

8165

1.17

6.91

2.1

2.3

133.31

130.43

g/l

4.26

1051

6352

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

362

1.83

6.82

1.0

1.1

0.54

5.93

u/ml

0.58

178

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

159

690

1.59

6.80

1.1

3.04

4.86

u/ml

0.35

457

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

434

2272

1.32

6.76

1.2

1.1

1.05

1.06

ratio

1.30

359

1905

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

262

1.97

6.69

1.0

2.99

0.69

u/ml

0.52

244

(4268621) Lupus anticoagulant assay

757

4248

1.23

6.67

2.4

2.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

163

715

1.57

6.67

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

163

716

1.57

6.63

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

352

1.82

6.55

1.7

1.9

1.31

1.33

umol/l

0.26

256

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1623

9748

1.15

6.54

1.5

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

1174

6880

1.18

6.52

2.4

2.6

17.10

16.63

5.87

1142

6730

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

162

715

1.56

6.47

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

312

1565

1.37

6.46

1.1

14.69

9.24

u/ml

1.18

278

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

101

394

1.77

6.45

1.0

0.28

0.30

u/ml

0.05

242

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.86

6.44

2.3

1.7

459.86

1755.77

umol/l

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1387

8247

1.16

6.42

3.1

3.5

8.50

8.36

kpa

2.52

1360

8050

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

338

1720

1.35

6.40

1.4

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1388

8267

1.16

6.29

1.6

1.7

10039.76

13368.55

e6/l

2.82

954

5922

(40757494) Bilirubin.total [Moles/volume] in Blood

302

1514

1.37

6.29

1.9

2.2

18.25

36.06

umol/l

2.12

148

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

106

423

1.73

6.28

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

399

2090

1.32

6.23

1.1

1.12

1.11

u/l

0.06

147

862

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

426

2259

1.30

6.09

1.5

26.00

24.03

u/ml

0.33

397

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

418

2211

1.30

6.09

1.6

2.2

100.70

98.00

0.83

375

2081

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

264

1302

1.40

6.08

2.0

150.78

169.51

2.99

242

1241

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

602

3333

1.25

6.06

1.5

1.3

1.50

1.45

nmol/l

0.56

559

3002

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1588

9580

1.14

6.04

1.4

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.70

6.03

1.1

—

mmol/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

173

790

1.51

5.97

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

378

1985

1.31

5.83

1.3

242.80

509.51

titre

1.39

122

(3010375) cycloSPORINE [Mass/volume] in Blood

153

1580

0.67

5.80

25.9

29.9

108.35

117.38

ug/l

1.08

123

1293

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

265

1321

1.38

5.76

1.1

1.0

9.29

11.21

u/ml

0.84

173

854

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

535

2942

1.25

5.75

3.6

4.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

154

692

1.53

5.74

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

973

5681

1.18

5.71

1.2

1.20

1.07

0.19

267

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

155

2.18

5.71

1.5

448.71

538.41

nmol/l

0.67

155

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1093

6446

1.17

5.68

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

368

1935

1.31

5.64

1.3

103.08

73.76

titre

0.25

141

(40768800) Prostate Pathology biopsy report

609

5127

0.82

5.63

1.2

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

3.12

5.59

3.0

3.1

1.98

2.89

ug/l

1.96

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

287

1458

1.36

5.57

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

321

1660

1.33

5.54

1.2

2.85

13.37

u/ml

2.54

190

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

522

2880

1.25

5.47

1.1

293.73

389.32

mg/l

0.46

480

2629

(3023383) Lactate [Moles/volume] in Pleural fluid

909

0.57

5.47

1.4

1.3

3.82

3.33

mmol/l

0.41

837

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

358

1.73

5.45

1.0

1.1

0.25

2.13

u/ml

1.59

269

(3005033) Fetal Nuchal fold Thickness US

1546

9386

1.14

5.40

1.4

1.5

1.29

1.25

2.02

1117

6894

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1461

8837

1.14

5.40

1.4

1.5

—

(3042733) HLA Ab [Presence] in Serum

126

1328

0.65

5.32

5.5

5.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

100

414

1.66

5.26

1.0

0.26

0.50

u/ml

0.33

198

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1589

9682

1.13

5.25

1.4

1.5

10.48

14.57

iu/ml

0.98

225

(3051387) C reactive protein [Mass/volume] in Capillary blood

858

6942

0.85

5.17

3.7

3.3

22.75

26.82

mg/l

3.08

545

4765

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

101

422

1.65

5.14

1.0

4.81

2.29

u/ml

0.21

198

(3026250) Tacrolimus [Mass/volume] in Blood

182

1776

0.70

5.14

41.8

42.7

7.24

7.31

ug/l

0.24

166

1613

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

146

666

1.51

5.13

1.3

1.2

98.60

59.81

mg/l

0.32

467

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

239

1.87

5.11

1.0

1.1

0.03

0.16

u/ml

1.28

239

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5917

38380

1.07

5.08

3.5

4.6

227.12

243.04

u/l

17.82

5583

36578

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4465

32890

0.93

5.06

3.4

4.4

11.56

25.97

ug/l

5.16

3415

26429

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

108

462

1.61

5.03

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

628

3572

1.21

4.98

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

643

3666

1.21

4.98

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1542

9414

1.13

4.97

1.7

—

(3021901) Oxygen saturation in Capillary blood

1133

6782

1.15

4.91

2.7

3.0

91.16

90.48

3.84

1105

6600

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

282

1461

1.33

4.87

1.1

796.89

358.26

ng/l

0.36

395

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

295

1539

1.32

4.86

1.1

95.08

97.70

0.80

227

1230

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

392

1.65

4.85

1.0

2.86

0.51

u/ml

0.45

191

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

936

5531

1.17

4.82

1.3

17.20

21.71

u/l

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

215

1.89

4.79

1.0

23.25

16.12

u/ml

0.41

169

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2388

14972

1.10

4.77

1.8

1.48

1.52

g/l

1.27

2056

12918

(3016750) Collection duration of Urine

188

1799

0.72

4.76

2.0

2.3

504.32

499.42

min

0.26

129

1374

(3033923) Metanephrine [Moles/time] in 24 hour Urine

139

641

1.49

4.68

1.1

1.30

2.86

umol/24h

0.31

325

(3016031) Almond IgE Ab [Units/volume] in Serum

292

1.74

4.67

1.0

1.1

0.34

0.63

u/ml

0.98

165

(3012494) Peanut IgE Ab [Units/volume] in Serum

208

1035

1.38

4.67

1.0

1.1

4.67

7.09

u/ml

0.21

123

597

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

243

1.81

4.59

1.0

2.37

2.07

u/ml

0.05

194

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

547

3097

1.22

4.59

1.3

1.2

56.86

70.98

u/ml

0.53

115

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

862

5083

1.17

4.59

1.1

1.48

1.50

g/l

1.06

795

4663

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1275

7737

1.14

4.56

1.4

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.40

4.55

1.0

0.29

0.51

u/ml

0.48

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

200

1.89

4.51

1.1

1.2

3.26

3.82

u/ml

0.10

163

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1201

7265

1.14

4.51

1.4

1.5

144.96

148.33

au/ml

0.42

316

2060

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

639

3685

1.20

4.43

2.9

3.5

3.66

8.93

nmol/l

1.76

620

3561

(3027974) Hepatitis B virus e Ag [Presence] in Serum

221

1.84

4.43

1.7

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

925

5502

1.16

4.42

1.4

1.5

14.59

13.84

u/ml

0.05

119

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1298

7904

1.13

4.41

1.4

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

831

4905

1.17

4.39

1.3

1.4

6.95

7.05

mmol/l

0.51

763

4331

(3051651) Icteric interference index of Serum or Plasma

338

1826

1.28

4.34

2.9

3.9

0.83

0.88

index

0.47

332

1779

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

905

7181

0.87

4.31

2.2

2.4

117.85

108.79

ug/min

0.19

534

4318

(3001893) Eosinophils/Leukocytes in Pleural fluid

842

0.61

4.30

1.4

3.99

2.84

0.46

711

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

463

2596

1.23

4.30

1.4

11.29

12.51

umol/l

3.34

437

2455

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1801

11204

1.11

4.24

2.4

2.7

3.60

g/l

0.06

1711

10755

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

188

937

1.38

4.23

1.7

9.31

9.22

ug/l

0.09

188

937

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

626

3622

1.19

4.21

1.2

64.23

63.67

u/l

0.06

544

3203

(3024471) HLA-A [Type]

120

1213

0.68

4.21

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

323

2813

0.79

4.21

1.3

476.57

506.59

u/l

0.12

306

2670

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

223

1143

1.34

4.21

1.2

1.1

8.50

5.04

u/ml

0.50

(3024932) HLA-DR beta [Type]

117

1188

0.68

4.21

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

307

1646

1.29

4.20

2.1

2.0

8.12

8.08

mmol/l

0.05

307

1646

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

158

765

1.42

4.20

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

694

4055

1.18

4.17

1.1

0.75

2.07

iu/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

220

1128

1.34

4.15

2.7

3.1

26.48

29.04

umol/l

2.86

159

871

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

404

1.59

4.14

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

155

750

1.42

4.14

1.7

1.4

0.24

0.29

mmol/l

0.32

123

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

127

592

1.48

4.12

1.1

2.58

38.59

iu/ml

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

168

826

1.40

4.10

1.2

1.3

104.82

107.74

0.62

153

787

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

959

5762

1.15

4.03

1.1

14.42

3.76

—

(3038026) Centromere Ab [Units/volume] in Serum

472

2673

1.22

4.01

1.3

1.2

51.94

52.29

u/ml

0.01

178

(3004119) Hemoglobin [Mass/volume] in Venous blood

3155

20191

1.08

3.99

3.2

3.4

132.23

129.61

g/l

9.11

3070

19635

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.25

3.99

1.0

—

(3000330) Specific gravity of Urine by Test strip

2189

16429

0.91

3.99

3.0

3.3

1.02

ratio

4.14

1913

14721

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

220

1136

1.33

3.98

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

636

3706

1.18

3.97

1.2

47.37

45.39

u/ml

0.06

190

(3006270) Folate [Moles/volume] in Blood

429

2409

1.23

3.97

1.1

1.2

401.67

369.34

nmol/l

2.77

399

2027

(3003434) Protein [Mass/volume] in Pleural fluid

491

4064

0.83

3.96

1.5

1.4

33.24

33.34

g/l

0.06

450

3701

(3018001) Oat IgE Ab [Units/volume] in Serum

276

1.70

3.96

1.0

0.35

0.71

u/ml

0.44

158

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

291

1568

1.28

3.87

1.1

0.11

0.48

—

(4035726) Immunohistochemistry procedure

3963

29022

0.94

3.85

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

270

1442

1.29

3.85

2.3

2.5

49.41

51.52

umol/l

0.51

237

1258

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.42

3.80

1.0

1.95

0.72

u/ml

0.30

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

171

859

1.37

3.72

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

918

5533

1.14

3.72

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

467

2665

1.21

3.71

3.3

2.5

25.89

28.08

mg/l

0.59

338

1910

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1275

7850

1.12

3.68

1.3

1.5

28.78

20.91

u/ml

0.53

152

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

272

1.67

3.66

1.1

87.27

95.88

titre

0.46

272

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

257

1374

1.29

3.66

2.7

133.32

153.74

au/ml

0.33

203

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

170

857

1.37

3.63

1.6

0.39

ug/l

0.04

123

622

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

239

0.35

3.61

1.1

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

675

0.61

3.55

1.4

18.67

23.67

0.81

565

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

119

2.02

3.54

1.0

1.1

0.04

0.11

u/ml

0.44

119

(3036071) Salmonella sp Ab [Titer] in Serum

217

1140

1.31

3.53

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

156

780

1.38

3.52

1.2

100.68

86.90

1.71

227

(3020779) Urea [Moles/volume] in Serum or Plasma

4490

29222

1.06

3.52

6.0

8.2

8.40

9.62

mmol/l

27.87

4302

27970

(3032057) Clostridioides difficile [Presence] in Stool

124

596

1.43

3.50

1.7

1.8

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

426

0.52

3.49

1.4

8.70

13.52

0.66

221

(3040151) Glucose [Moles/volume] in Capillary blood

635

3747

1.17

3.47

14.0

5.9

7.27

7.29

mmol/l

0.02

525

3097

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

330

1.59

3.46

1.8

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

365

2048

1.23

3.46

1.2

1.3

25.61

24.72

u/l

0.09

300

1744

(3035947) Staphylolysin Ab [Units/volume] in Serum

299

1642

1.25

3.45

1.1

4.21

3.62

iu/ml

0.41

128

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2959

19011

1.08

3.42

8.9

10.3

16.27

16.10

2.70

2873

18327

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1687

12712

0.91

3.41

2.0

1.75

2.35

ug/l

1.70

1478

11314

(3007700) Barley IgE Ab [Units/volume] in Serum

190

1.78

3.39

1.0

0.51

7.89

u/ml

0.49

(40768806) Pleura Pathology biopsy report

362

3032

0.82

3.38

1.6

1.5

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

981

0.69

3.36

1.4

57.92

62.94

0.81

806

(3013466) aPTT in Blood by Coagulation assay

211

1.73

3.36

1.2

1.1

35.54

36.93

1.00

181

(3007542) Rye IgE Ab [Units/volume] in Serum

217

1.71

3.32

1.0

0.49

9.45

u/ml

0.50

(3013945) Hepatitis B virus e Ab [Presence] in Serum

213

1.71

3.26

1.7

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

371

2101

1.22

3.24

1.2

1.3

84.38

91.47

u/l

0.69

309

1817

(3020123) Porphyrins [Interpretation] in Serum or Plasma

198

1.74

3.24

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

163

1.82

3.21

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1042

6398

1.12

3.21

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

298

2531

0.81

3.21

1.4

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1801

13488

0.92

3.20

4.8

5.2

0.88

0.12

1705

12754

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

114

550

1.43

3.19

1.0

0.27

u/ml

0.01

343

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

532

3119

1.18

3.19

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

154

783

1.35

3.17

1.2

81.07

76.14

0.28

218

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

164

842

1.34

3.17

1.2

65.79

68.38

ug/l

0.25

164

842

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

432

1.48

3.17

1.0

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

273

1.61

3.17

1.0

14.03

6.62

u/ml

0.95

161

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

813

0.67

3.16

1.3

59.59

282.71

ug/l

2.58

434

(3051611) Lipemic interference index of Serum or Plasma

537

3154

1.17

3.15

3.0

3.5

14.86

14.28

index

0.33

332

1782

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

226

1.68

3.14

1.0

1.1

9.02

8.76

u/l

0.05

226

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

549

3233

1.17

3.12

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.09

3.12

1.0

1.1

0.05

0.08

u/ml

0.41

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

281

1557

1.24

3.05

3.7

3.4

8.53

8.64

mg/l

0.09

222

1265

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

133

666

1.38

3.03

1.3

1.18

mmol/l

0.13

133

666

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

529

3116

1.17

3.01

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

358

2038

1.21

3.00

1.9

98.77

99.51

ng/l

0.05

358

2032

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.29

2.90

1.3

2.9

2.27

2.80

mu/l

0.15

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

473

3807

0.85

2.87

1.9

2.0

27.07

25.53

ug/l

0.11

465

3728

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

242

0.43

2.87

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

281

1.57

2.85

1.5

1.4

7.65

13.90

pmol/l

1.63

236

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

125

1.87

2.83

2.1

2.0

262.13

241.91

ug/l

0.22

125

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.10

2.82

1.0

1.4

161.44

116.62

nmol/l

0.74

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

404

1.47

2.81

1.9

1.8

1.58

1.76

mg/l

0.71

341

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3063

19852

1.07

2.80

6.6

7.0

24.48

24.53

mmol/l

0.36

2960

18977

(40759836) Histone Ab [Presence] in Serum by Immunoblot

534

3169

1.16

2.80

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

475

1.42

2.73

1.8

1.5

231650.37

217699.79

nmol/l

0.03

390

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

677

4095

1.14

2.72

2.1

2.2

32.58

32.42

0.44

672

4068

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

495

2929

1.16

2.71

1.2

98.75

216.93

titre

—

101

(3035880) pH of Pleural fluid

176

1552

0.78

2.71

1.3

7.43

7.41

0.43

107

1100

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

509

3019

1.16

2.70

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

496

2937

1.16

2.69

1.2

188.40

205.41

titre

0.15

455

(3010370) Gastrin [Moles/volume] in Serum or Plasma

111

552

1.38

2.68

1.8

1.9

40.47

56.91

pmol/l

0.56

471

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

507

3017

1.16

2.59

1.2

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

223

1.61

2.58

1.6

1.4

39.95

36.31

0.26

149

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

162

860

1.30

2.56

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

111

558

1.37

2.54

1.8

2.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1012

6298

1.11

2.54

1.2

1.3

130.00

129.77

titre

—

131

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

235

1.58

2.53

1.3

1.4

16.47

15.54

pmol/l

0.09

202

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

266

2221

0.82

2.52

1.3

13.51

14.79

u/l

0.44

245

2041

(3007919) Fasciola sp Ab [Titer] in Serum

2.19

2.51

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

527

0.64

2.50

1.6

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

162

865

1.29

2.47

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

194

1.63

2.46

1.0

1.1

—

(3033099) Centromere Ab [Titer] in Serum

164

878

1.29

2.45

1.1

—

(3012441) Differential panel - Pleural fluid

382

3079

0.85

2.43

1.5

—

1.00

—

(40757373) Influenza virus identified in Isolate

597

0.67

2.41

1.5

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

224

0.46

2.40

3.1

6.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

142

748

1.31

2.40

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

2.75

2.37

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

419

2477

1.17

2.37

1.5

1.8

6.66

mmol/l

0.00

341

1821

(3022475) Manganese [Moles/volume] in Blood

196

1.62

2.37

1.2

1.3

0.16

umol/l

0.02

196

(3033942) Copper [Moles/time] in 24 hour Urine

159

1.69

2.37

1.3

1.2

1.05

0.74

umol/24h

0.21

(3018333) Ribosomal P Ab [Presence] in Serum

491

2938

1.15

2.37

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

168

908

1.27

2.35

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

168

908

1.27

2.35

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

168

908

1.27

2.35

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

168

908

1.27

2.35

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1582

11736

0.93

2.34

3.2

3.6

280.34

1891.51

u/ml

2.21

1346

10135

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.93

2.32

1.1

1.2

27.21

46.37

umol/24h

0.61

(3047189) Immunofixation for 24 hour Urine

160

1394

0.79

2.29

1.7

1.9

—

(40758292) HTLV I+II Ab panel - Serum

735

0.71

2.27

1.2

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

242

1.54

2.27

1.1

27.82

27.31

u/ml

0.01

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

242

1.54

2.27

1.1

15.82

23.13

u/ml

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2458

15946

1.06

2.25

3.8

4.0

51.09

47.74

9.12

2427

15736

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

928

5792

1.10

2.25

1.1

244.43

2645.74

iu/ml

0.70

206

1207

(3003129) Base excess in Capillary blood by calculation

625

3820

1.13

2.21

2.1

2.2

0.60

0.51

mmol/l

0.25

599

3654

(3052592) Norovirus Ag [Presence] in Stool

618

0.69

2.21

1.0

1.4

—

(40765096) Chromosome analysis panel by Banding

107

975

0.75

2.19

1.1

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

4.02

2.18

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

162

882

1.26

2.16

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

504

1.35

2.15

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

165

1419

0.80

2.14

3.0

3.3

1.55

1.32

0.94

165

1419

(3035060) Mercury [Moles/volume] in Blood

2.29

2.12

2.6

1.5

11.44

10.08

nmol/l

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

263

1.49

2.12

1.1

1.2

15.15

17.12

nmol/l

0.30

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

317

1852

1.18

2.12

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

246

1406

1.20

2.11

4.0

4.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

864

0.75

2.07

1.1

1.3

—

(3003577) Lead [Moles/volume] in Blood

305

1.44

2.04

1.6

1.5

0.21

0.37

umol/l

0.96

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

438

1.37

2.04

1.6

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

172

0.44

2.03

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

992

6253

1.09

2.00

1.2

1.3

293.24

300.99

titre

0.04

459

(3000060) B lymphocytes [#/volume] in Blood

198

1116

1.22

1.97

1.7

2.1

0.18

0.61

e9/l

1.01

513

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

133

0.41

1.97

2.0

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1037

1.23

1.95

4.1

3.0

10.63

10.43

kpa

0.35

185

1037

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1037

1.23

1.95

4.1

3.0

4.79

4.93

kpa

1.33

185

1037

(43055442) Apixaban [Mass/volume] in Serum or Plasma

466

1.34

1.94

1.7

1.6

111.32

111.86

ug/l

0.02

382

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.12

1.91

1.0

0.04

0.20

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

340

2018

1.16

1.91

1.5

1.6

5.79

6.97

u/l

0.96

258

1609

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

254

1472

1.19

1.91

2.0

2.1

8.99

9.14

mg/l

0.16

205

1218

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5819

38727

1.04

1.91

4.9

4.7

31.92

32.26

1.52

4095

26770

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

168

1421

0.81

1.91

2.2

2.1

32.40

110.11

ug/min

3.21

326

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

213

0.52

1.90

1.1

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

498

1.33

1.89

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

504

1.33

1.89

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

248

1.47

1.88

3.2

3.0

11.51

384.22

pmol/l

0.68

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

328

1.41

1.88

1.0

0.04

0.05

u/ml

0.27

328

(1617658) Protocol used for examination of sentinel lymph nodes

403

2425

1.14

1.88

1.0

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

274

0.58

1.87

2.8

2.2

76.22

58.90

—

173

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

133

1.66

1.87

1.1

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.15

1.86

1.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.95

1.86

1.5

1.4

399.16

404.88

mg/24h

0.03

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

217

1244

1.20

1.85

1.1

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

166

1.58

1.84

1.6

1.3

1.90

1.69

0.08

108

(3037692) Legionella sp identified in Specimen by Organism specific culture

131

1133

0.80

1.84

1.3

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

879

5536

1.09

1.83

1.2

1.3

27.91

33.11

u/l

0.48

762

4836

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

642

0.73

1.83

1.1

1.4

250.00

142952.03

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

467

3621

0.89

1.80

1.5

4384.53

3397.34

e6/l

0.37

308

2540

(21491868) Cryoglobulin [Mass/volume] in Serum

219

1262

1.19

1.78

1.2

0.11

0.54

g/l

—

(3018133) Calcium [Moles/volume] in Urine

127

691

1.27

1.77

1.5

1.8

2.54

2.77

mmol/l

0.72

115

638

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1309

8396

1.07

1.76

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

252

1.45

1.76

1.2

—

(3017704) Immunofixation for Urine

203

1670

0.84

1.76

1.4

1.7

—

(3024263) Appearance of Synovial fluid

266

1561

1.17

1.75

1.7

1.8

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

192

1096

1.21

1.73

1.7

154.72

124.26

au/ml

0.29

163

(3012516) Albumin [Mass/volume] in Urine

15424

104310

1.02

1.73

3.3

3.6

44.07

49.60

mg/l

1.70

9661

66390

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1663

10762

1.07

1.73

2.8

3.6

1.37

1.50

mg/l

10.54

1533

9912

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

434

0.68

1.72

1.4

1.3

28.52

224.38

u/l

1.15

312

(3004446) Plasmodium sp identified in Blood by Light microscopy

423

1.33

1.70

2.2

2.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

164

1.55

1.70

1.1

1.0

0.09

0.08

0.34

116

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

552

0.72

1.67

5.5

6.8

10.82

10.66

0.19

552

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

255

1.43

1.67

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

171

1.53

1.65

1.2

1.1

1.11

1.21

u/field

0.49

114

(3020876) Protein [Mass/time] in 24 hour Urine

527

4030

0.90

1.63

2.4

2.5

1.15

1.31

g/24h

0.70

283

2447

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

433

2649

1.13

1.61

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

356

1.35

1.61

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

428

1.32

1.60

1.9

2.4

0.98

1.23

mmol/l

0.53

284

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

342

2065

1.14

1.58

1.7

1.8

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

155

1290

0.83

1.56

1.5

1.8

14723.08

24812.17

u/ml

0.33

177

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

202

1.47

1.55

1.0

1.1

44.89

55.13

u/l

0.57

167

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.17

1.55

1.1

4042.17

3540.89

titre

0.24

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

117

643

1.25

1.54

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

840

0.79

1.54

9.9

8.2

5.94

5.96

kpa

0.12

746

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7507

52970

0.97

1.53

3.1

3.0

0.66

0.75

ug/l

7.87

4393

32171

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

311

1872

1.14

1.51

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

102

553

1.27

1.51

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

714

0.77

1.51

1.4

2.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

586

3662

1.10

1.51

1.3

1.4

8.66

8.20

mmol/l

1.62

566

3503

(3016330) Potassium [Moles/time] in 24 hour Urine

499

1.28

1.50

1.4

1.3

88.69

75.39

mmol/24h

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.68

1.50

1.0

1.1

19.29

18.44

umol/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

212

1242

1.18

1.48

1.1

—

(3004541) Aldosterone [Moles/volume] in Urine

2.95

1.48

1.3

1.1

41.67

37.21

nmol/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

416

3200

0.89

1.47

1.5

1.4

76385.10

49645.31

e6/l

0.45

214

1795

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

338

0.67

1.47

1.1

1.2

0.11

0.34

u/ml

1.16

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

229

0.60

1.46

2.4

2.7

—

(3000034) Microalbumin [Mass/volume] in Urine

433

2671

1.12

1.44

3.0

44.63

55.45

mg/l

0.50

311

1903

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

200

1.45

1.43

1.8

1.4

13.11

12.83

0.03

143

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2042

14751

0.95

1.43

4.5

5.0

1.75

1.64

3.41

1941

13985

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

412

1.30

1.43

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

218

1286

1.17

1.42

2.0

2.1

66.98

58.96

ug/l

0.61

212

1262

(3023487) Leukocytes [#/volume] in Peritoneal fluid

146

1207

0.83

1.40

2.0

662.88

2614.01

e6/l

1.46

793

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1410

10283

0.94

1.40

2.9

3.3

0.36

0.35

iu/ml

0.42

739

5641

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

100

859

0.80

1.40

1.6

1.9

31.18

38.95

u/l

0.21

782

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.65

1.38

1.2

33.86

32.08

mg/24h

0.17

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

308

0.67

1.37

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.22

1.36

1.1

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

314

1.34

1.35

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

506

0.75

1.33

1.2

1.50

1.31

mmol/l

0.08

333

(3013336) Amino acids [Identifier] in Serum or Plasma

1.72

1.33

2.5

2.7

—

(40768446) Kidney Pathology biopsy report

191

1532

0.86

1.31

1.9

1.7

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

103

572

1.24

1.29

2.0

1.20

1.19

mmol/l

0.42

546

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

316

1929

1.13

1.29

1.2

1.1

80.92

83.27

u/l

0.19

281

1725

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1362

8858

1.06

1.29

1.5

1.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

101

560

1.24

1.29

1.8

2.0

1.19

1.18

mmol/l

0.69

531

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

394

2439

1.11

1.27

1.8

2.6

552.91

527.63

e6/l

0.30

301

1961

(3013862) HLA-DP [Type]

151

0.55

1.27

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

288

1.34

1.26

1.1

1.0

6.60

4.20

u/ml

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

211

0.62

1.26

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

150

0.55

1.24

1.0

10.64

8.56

mu/l

0.52

121

(3047181) Lactate [Moles/volume] in Blood

1520

9931

1.05

1.24

4.8

5.7

1.30

mmol/l

0.02

1353

8787

(40760410) HLA-B [Type] by High resolution

149

0.55

1.22

1.0

—

(40760409) HLA-A [Type] by High resolution

149

0.55

1.22

1.1

1.0

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

317

1945

1.12

1.21

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.43

1.21

1.0

1.1

24.17

32.53

umol/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1319

8592

1.06

1.20

1.4

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

488

3065

1.10

1.20

1.4

129322.11

109439.96

e6/l

0.24

319

2017

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

449

1.26

1.19

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

511

1.24

1.18

1.9

2.1

—

(40768795) Lymph node Pathology biopsy report

457

3448

0.91

1.17

1.2

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

123

1.51

1.17

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

106

0.52

1.17

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

2.65

1.17

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

312

1918

1.12

1.16

1.2

1.1

22.46

23.50

u/l

0.12

280

1715

(40765089) Chromosome analysis panel - Blood by G-banded

238

1439

1.14

1.16

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

239

1.35

1.16

1.6

1.8

50.72

47.18

umol/l

0.23

239

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1007

6518

1.06

1.15

1.2

1.3

—

(3019174) dRVVT (LA screen)

311

1.31

1.15

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.63

1.14

1.5

1.1

—

(3044927) Protein electrophoresis panel - Urine

382

2901

0.91

1.14

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

745

0.81

1.13

10.2

8.1

5.79

5.69

kpa

0.11

745

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

274

1676

1.13

1.12

1.5

1.7

2.41

2.46

u/field

0.04

201

1200

(3001729) Color of Synovial fluid

237

0.67

1.11

2.4

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

127

1033

0.85

1.09

1.9

1.8

13241.83

11575.25

e6/l

0.08

515

(3004809) Band form neutrophils/Leukocytes in Blood

744

5480

0.93

1.08

2.6

3.4

1.52

1.53

0.01

658

4932

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

406

1.25

1.08

2.4

2.9

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

202

0.65

1.07

2.7

1.7

0.49

0.65

0.27

153

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

327

1.28

1.07

1.0

1.1

1.72

2.83

umol/24h

0.49

327

(3018572) Chloride [Moles/volume] in Blood

926

6766

0.94

1.06

6.1

6.9

104.71

105.10

mmol/l

1.58

849

6090

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

105

0.52

1.06

1.0

1.1

—

(3039000) Anion gap in Blood by calculation

926

6765

0.94

1.05

6.1

6.8

11.51

11.25

mmol/l

1.59

849

6087

(3017569) Oxygen content in Arterial blood

275

1691

1.12

1.05

2.4

2.2

16.29

15.95

0.89

275

1691

(3044007) Cell count panel - Peritoneal fluid

126

1022

0.85

1.05

1.9

—

(3034614) HLA Ag [Interpretation]

1.59

1.05

1.1

1.3

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.55

1.05

1.0

0.01

0.18

u/ml

0.87

(46236302) HLA-C [Type] by High resolution typing

150

0.60

1.04

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

303

1876

1.11

1.03

1.1

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

242

1479

1.13

1.03

1.9

2.3

9.00

9.77

0.67

233

1379

(3003329) Lymphocytes/Leukocytes in Synovial fluid

480

3039

1.09

1.03

1.5

1.6

33.63

32.07

0.39

283

1888

(3005570) Glucose [Moles/volume] in Urine

509

3231

1.08

1.03

2.1

1.9

14.66

20.53

mmol/l

—

(3045142) Bone marrow Pathology biopsy report

478

3572

0.92

1.03

1.2

1.4

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.09

1.02

1.1

1.0

0.86

0.93

u/ml

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

100

571

1.21

1.02

1.2

1.3

889.20

229.02

titre

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3598

24052

1.03

1.02

2.6

3.0

158.01

187.03

ng/l

4.21

3268

21935

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

139

1.44

1.02

1.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

1.00

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

1.00

0.0

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

231

1411

1.13

1.00

1.7

2.1

27.59

29.84

2.07

223

1345

(40763590) HLA-DQ beta [Type]

148

0.60

1.00

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

105

860

0.84

1.00

1.5

1.4

13.07

13.69

g/l

0.28

652

(4281824) Cell count and differential, peritoneal fluid

507

3773

0.92

1.00

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

151

897

1.16

0.99

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

238

0.69

0.98

1.8

2.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

152

1.40

0.98

1.5

0.00

0.16

u/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

147

0.61

0.97

1.2

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1049

6842

1.06

0.97

2.1

2.3

0.89

0.87

nmol/l

0.38

897

5821

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

259

1.30

0.97

1.3

1.2

104.74

101.32

ug/l

0.05

158

(3028433) Virus identified in Specimen by Culture

171

1027

1.15

0.97

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

227

1389

1.13

0.97

2.4

2.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

149

886

1.16

0.97

1.6

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

15603

106128

1.02

0.95

3.9

4.3

7.41

8.80

mg/mmol

3.32

9542

66253

(44790048) Parainfluenza type 2 nucleic acid detection

694

4474

1.07

0.95

1.3

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

693

4471

1.07

0.93

1.3

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

693

4472

1.07

0.93

1.3

1.5

—

(4146454) Self-monitoring of blood glucose

449

3345

0.92

0.93

2.6

2.8

—

(3037121) Protein [Mass/volume] in Urine

1710

11306

1.04

0.92

2.9

3.4

761.46

509.90

mg/l

0.50

713

5291

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

194

0.67

0.92

6.4

5.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

693

4475

1.07

0.91

1.3

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

970

7038

0.95

0.91

2.7

3.5

—

271.01

—

(3045788) Cell count panel - Pleural fluid

391

2925

0.92

0.90

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

386

1.23

0.89

1.6

3.4

41.24

41.86

umol/l

0.08

336

(3016273) Islet cell 512 Ab [Units/volume] in Serum

245

1.29

0.88

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.06

0.88

1.7

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

261

1622

1.11

0.87

1.3

1061.36

1050.84

titre

0.04

356

(4212803) Bone marrow aspirate examination

246

1.29

0.86

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

150

0.64

0.86

3.2

3.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

398

2527

1.08

0.85

2.0

2.7

230.67

230.19

e6/l

0.02

322

2141

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

1234

0.88

0.84

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

1234

0.88

0.84

1.7

2.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.51

0.84

1.7

1.2

16.26

8.39

mg/l

—

(3008896) Cortisol [Moles/volume] in Urine

1.97

0.84

1.2

68.00

79.33

nmol/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

105

844

0.86

0.84

1.2

15.26

10.87

pmol/l

0.38

310

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.61

0.82

1.0

1.1

0.04

0.61

u/ml

1.33

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

168

1023

1.13

0.82

1.8

1.7

146.20

202.73

iu/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

170

1.34

0.81

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

104

612

1.17

0.81

2.4

2.8

30.64

45.40

mg/l

0.62

142

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1776

11792

1.04

0.80

1.9

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

308

1941

1.09

0.80

1.3

1.4

5.55

5.58

mmol/l

0.14

292

1838

(21494815) CD4 cells/Lymphocytes in Specimen

487

3128

1.07

0.79

2.0

2.2

42.83

38.69

8.27

480

3076

(3011412) CD3 cells [#/volume] in Blood

529

3408

1.07

0.79

2.0

2.5

1332.51

1208.79

e6/l

1.74

447

2991

(21494890) Protein electrophoresis panel - 24 hour Urine

430

3180

0.93

0.78

1.8

2.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

551

1.17

0.78

1.2

1.4

83.58

247.02

ng/l

0.55

356

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

387

1.21

0.77

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.50

0.77

1.7

1.4

1.43

2.09

mmol/24h

1.86

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

666

0.85

0.76

6.6

6.0

8242.00

5980.79

iu/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

413

1.20

0.76

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.54

0.76

1.0

1.1

3.07

2.66

0.26

(3012565) Volume of 24 hour Urine

261

1638

1.10

0.75

2.1

2.2

2051.67

1990.49

0.34

235

1484

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

326

2067

1.09

0.75

6.8

7.3

20.34

68.24

ug/l

1.78

205

1364

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

264

0.76

0.75

1.3

1.38

1.49

ml/s/173m2

0.11

170

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

427

1.19

0.74

1.5

1.3

49.88

52.30

0.17

203

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

162

1250

0.89

0.74

1.7

2.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

240

1.26

0.74

1.0

1.1

3.88

1.00

u/ml

0.53

162

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

700

0.86

0.73

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

286

0.77

0.73

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

346

1.21

0.73

1.0

1.1

1.11

1.18

mom

0.41

346

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

176

0.70

0.73

1.1

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

2.02

0.73

4.0

1.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.65

0.71

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.65

0.71

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

771

5577

0.95

0.70

3.8

3.3

0.79

0.80

nmol/l

0.25

642

4463

(3044009) aPTT.lupus sensitive (LA screen)

329

1.21

0.70

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

317

1.22

0.69

1.1

757.67

281.21

u/ml

0.78

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

182

0.72

0.69

3.0

3.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2042

14472

0.97

0.68

3.3

3.5

25.13

25.30

mmol/l

1.54

1962

13994

(3042301) Urate [Moles/volume] in Synovial fluid

1.54

0.67

1.0

401.33

367.63

umol/l

—

(3027874) Urate [Moles/volume] in Urine

116

1.36

0.67

1.0

1.1

1.77

6.51

mmol/l

0.50

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1016

7288

0.96

0.66

1.5

1.6

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

1.81

0.66

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

574

1.15

0.65

2.0

2.4

6.66

7.55

mmol/l

1.96

348

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.47

0.65

1.0

0.02

0.10

u/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1929

12891

1.03

0.65

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.64

0.64

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.64

0.64

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.64

0.64

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.64

0.64

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.64

0.64

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.64

0.64

1.0

—

(3049233) Organic acids panel - Urine

1.64

0.64

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

214

1.25

0.64

1.3

3.2

14.80

11.83

—

(3037756) Immunofixation for Serum or Plasma

897

6446

0.96

0.64

1.4

1.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

227

1.24

0.63

1.7

1.5

302.29

309.43

umol/24h

0.08

227

(3044336) Cobalt [Moles/volume] in Urine

1.43

0.63

2.3

2.6

23.96

27.67

nmol/l

0.11

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.72

0.62

1.0

—

(3024316) Viscosity of Plasma

160

1.29

0.62

1.9

1.7

1.89

1.53

mpas

0.86

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

379

1.18

0.61

1.1

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

1.45

0.61

1.5

1.3

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.10

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

284

2104

0.93

0.59

2.6

2.8

41.75

39.50

1.38

146

1154

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

143

1.30

0.59

7.9

9.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

420

3069

0.94

0.59

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.53

0.59

1.0

0.08

0.13

u/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

381

0.83

0.58

2.1

2.3

0.70

0.65

u/field

0.09

381

(21494434) Karyotype in Bone marrow

374

2740

0.94

0.58

1.1

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

136

0.71

0.57

1.0

1.1

—

(4211845) Urine protein measurement

261

1665

1.08

0.57

2.5

2.9

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.55

0.57

2.2

1.3

0.45

2.80

mmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

350

0.83

0.57

2.3

3.0

1.65

1.20

mg/l

0.58

232

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.36

0.56

1.1

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

1.33

0.56

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.65

0.56

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

513

0.86

0.56

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

200

1.24

0.56

1.0

1.1

3.53

2.78

u/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

218

1626

0.92

0.56

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

218

1626

0.92

0.56

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

481

3139

1.05

0.54

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

442

1.15

0.54

2.7

2.9

54.60

75.26

pmol/l

1.09

383

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

383

2483

1.06

0.54

19.7

21.2

1303.27

2702.05

nmol/l

1.14

371

2394

(3009015) Lactate [Moles/volume] in Synovial fluid

321

1.18

0.53

1.2

1.3

5.13

6.47

mmol/l

0.99

155

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

344

2518

0.94

0.53

1.8

1.9

1.83

2.94

u/field

0.62

197

1416

(3023436) Glucagon [Mass/volume] in Serum or Plasma

177

1.24

0.52

1.6

1.9

178.23

202.85

ng/l

1.31

157

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

382

2481

1.06

0.52

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

196

1.23

0.52

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

510

3340

1.05

0.51

1.5

1.6

7.66

mmol/l

0.01

495

3203

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.35

0.51

1.0

1.02

3.12

u/ml

0.99

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

362

2349

1.06

0.51

15.4

15.8

757.26

2029.18

nmol/l

1.09

351

2274

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

315

0.83

0.50

1.8

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

373

2424

1.06

0.50

2.0

2.6

0.80

0.68

e9/l

3.06

355

2329

(4038314) Semen analysis, post vasectomy

343

1.16

0.49

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

587

0.88

0.49

1.2

138.51

138.29

mmol/l

0.20

493

(3000012) Reticulocyte production index

660

4355

1.04

0.49

2.1

2.2

0.95

0.91

0.69

421

2949

(1175426) CD3 cells/Lymphocytes in Blood

423

2761

1.05

0.49

1.9

2.1

74.71

72.95

2.34

407

2660

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.63

0.49

3.0

4.6

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

185

1.23

0.49

1.4

1.3

1.88

1.66

mg/l

0.46

157

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

290

1872

1.07

0.49

1.5

—

(40762814) Titanium [Mass/volume] in Blood

469

0.87

0.49

2.8

2.5

3.03

3.70

ug/l

0.87

180

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

217

1.21

0.48

1.1

—

(40768441) Liver Pathology biopsy report

359

2612

0.95

0.48

1.3

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

820

1.10

0.47

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

133

834

1.10

0.47

1.2

280.00

556.00

titre

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

277

1790

1.07

0.46

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.42

0.46

1.1

—

(3045177) Copper [Moles/volume] in Urine

1.42

0.46

1.1

0.40

0.37

umol/l

—

(3041184) Isoniazid [Presence] in Urine

1.42

0.45

1.6

2.7

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

491

3537

0.95

0.45

1.2

1.3

37.40

56.48

u/ml

—

(4015189) Microbial culture of sputum

118

738

1.10

0.44

2.1

2.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

113

1.28

0.44

1.0

1.1

0.20

0.21

g/l

0.58

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

421

2763

1.05

0.42

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

421

2763

1.05

0.42

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

421

2763

1.05

0.42

1.5

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

204

1310

1.07

0.42

2.9

3.1

—

(40758358) Immune stain study

143

0.77

0.42

1.0

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.42

0.0

2.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

229

1478

1.07

0.41

1.2

1.4

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

108

1.27

0.41

1.0

6823.67

9562.62

ng/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

232

1700

0.94

0.41

1.5

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

253

1.17

0.41

1.2

1.1

—

0.30

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

229

1479

1.07

0.41

1.2

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

439

0.88

0.40

7.8

8.8

0.37

0.41

umol/l

0.29

388

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

760

5057

1.03

0.40

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

150

1115

0.93

0.40

3.0

3.3

44.61

44.85

0.05

150

1115

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

150

1115

0.93

0.40

5.9

6.6

9.18

8.73

0.41

150

1115

(3006462) Nitrate [Presence] in Urine

234

1514

1.06

0.40

2.5

3.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

448

1.12

0.40

1.4

1.3

5.70

5.79

mmol/l

0.38

448

(3033086) Enterovirus Ab [Titer] in Serum

115

1.26

0.39

1.1

1.0

—

(3034891) Synovial lining cells/cells in Synovial fluid

252

1636

1.06

0.39

1.4

1.5

4.04

3.83

0.07

354

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

214

1567

0.94

0.38

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

347

2506

0.95

0.38

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

110

0.75

0.38

1.1

1.0

11.00

12.04

mg/l

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

122

1.24

0.38

1.1

1.0

0.10

0.13

u/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

307

1.14

0.38

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

403

2653

1.05

0.38

1.8

2.1

13.82

14.97

1.82

394

2585

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

159

1018

1.08

0.38

2.2

3.3

2.01

1.84

ratio

0.61

144

938

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

319

0.86

0.37

1.0

1.1

25.02

21.36

u/l

0.67

208

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.34

0.37

2.2

2.1

28.92

26.99

0.21

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

1.38

0.36

1.0

0.19

0.73

u/ml

—

(3040794) Aluminum [Moles/volume] in Urine

0.64

0.36

1.0

1.3

0.25

0.37

umol/l

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

301

1970

1.05

0.36

1.6

1.17

1.29

nmol/l

1.36

227

1511

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

468

3095

1.04

0.36

1.5

1.8

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

167

1.20

0.36

1.1

1.0

0.07

0.16

u/ml

0.65

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

360

2591

0.96

0.36

1.7

1.8

3.25

3.73

mg/l

1.64

343

2490

(3027035) Albumin [Mass/time] in 24 hour Urine

317

0.87

0.35

1.5

1.3

50.37

337.62

mg/24h

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.28

0.35

1.1

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

111

1.24

0.35

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.33

0.34

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

343

1.12

0.33

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

474

1.10

0.33

2.6

3.0

15.28

14.85

ml/dl

0.65

444

(3006969) Lambda light chains [Mass/volume] in Urine

1.27

0.33

1.3

1.1

0.20

0.02

g/l

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

427

2828

1.04

0.32

1.2

1.3

80.31

80.18

0.01

202

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

817

5775

0.97

0.32

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

234

1695

0.95

0.32

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

234

1695

0.95

0.32

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

234

1695

0.95

0.32

1.5

1.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

581

0.91

0.32

2.4

2.5

—

(3022670) pH of Venous cord blood

1.30

0.31

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.72

0.31

5.4

4.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

241

1.14

0.31

1.2

1.1

18.71

17.18

iu/ml

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

203

0.85

0.31

2.5

2.2

0.58

0.66

ug/l

0.82

203

(3014891) Appearance of Pleural fluid

349

0.89

0.30

1.9

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

222

1.15

0.30

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

406

0.90

0.30

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

210

1.15

0.29

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

232

1675

0.95

0.29

2.3

2.2

3.73

3.74

ug/l

0.01

219

1545

(3032641) Amino acids panel - Urine

1.31

0.28

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

411

2928

0.97

0.28

2.5

2.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

608

4070

1.03

0.27

1.5

1.6

51.15

56.58

2.44

369

2588

(3006576) Bicarbonate [Moles/volume] in Blood

153

995

1.06

0.26

4.9

6.4

24.67

25.17

mmol/l

0.80

146

897

(3025577) Chromium [Mass/volume] in Blood

226

1627

0.96

0.26

2.2

2.49

2.39

ug/l

0.16

194

1354

(3032868) Hemoglobin electrophoresis panel in Blood

350

1.10

0.26

1.4

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

167

1.15

0.26

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

145

1055

0.95

0.25

2.1

2.0

1.99

1.76

ratio

0.88

135

1020

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

457

3241

0.97

0.25

1.5

1.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

220

0.88

0.24

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

114

834

0.94

0.24

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.21

0.24

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

1.38

0.24

4.2

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

656

0.93

0.24

1.2

1.3

51.78

83.41

mu/l

1.00

490

(3023419) Bacteria identified in Sputum by Culture

615

4129

1.03

0.24

2.4

2.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

162

1.15

0.24

1.0

1.1

0.08

1.26

u/ml

1.71

162

(3014271) Vancomycin [Susceptibility]

188

1354

0.96

0.23

2.7

2.9

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

146

0.85

0.23

1.6

1.1

0.05

0.08

g/l

1.95

105

(4133840) Spirometry

137

993

0.95

0.22

1.1

1.2

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

712.50

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

152

0.86

0.21

1.0

0.01

0.34

u/ml

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.21

0.0

1.4

—

1.96

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

432

0.92

0.21

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

232

1538

1.04

0.21

2.4

5.0

3730.20

2195.10

mg/l

0.38

160

1111

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

164

1.13

0.21

21.1

12.7

105.19

106.13

g/l

0.17

164

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

293

2083

0.97

0.21

1.2

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

151

1.14

0.21

1.1

1.0

0.08

0.09

u/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

119

863

0.95

0.20

1.3

45.63

39.82

0.85

575

(3025311) HLA-B [Type]

0.00

0.20

0.0

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

885

5982

1.02

0.20

2.2

3.0

3199.37

6213.68

u/ml

0.49

339

(3035082) Kappa light chains [Mass/volume] in Urine

1.18

0.20

1.2

1.1

0.01

0.13

g/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

445

0.93

0.20

1.1

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.21

0.20

1.0

1.3

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

137

899

1.05

0.20

1.5

1.4

47.33

54.62

1.37

112

772

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

230

0.90

0.19

8.3

4.9

—

(3026480) Teichoate Ab [Titer] in Serum

284

1.09

0.19

1.1

—

2.83

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

585

0.94

0.19

1.3

1.2

1.78

1.65

mmol/l

0.31

367

(3000093) Morphology [Interpretation] in Blood Narrative

468

3146

1.02

0.19

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

718

0.95

0.18

2.9

2.7

214.98

407.56

ug/l

0.32

718

(3001964) Herpes simplex virus Ag [Presence] in Specimen

138

992

0.96

0.18

1.3

1.5

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

492

0.94

0.18

1.7

2.5

2.66

2.50

0.16

485

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

654

4586

0.98

0.18

2.4

2.5

20.75

27.79

iu/ml

1.18

419

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

124

815

1.05

0.17

2.2

2.8

102.40

101.34

ng/l

0.03

427

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

315

2228

0.97

0.17

1.4

12.26

12.78

u/l

0.70

308

2155

(3042631) Mycobacterium sp identified in Specimen

580

4071

0.98

0.17

2.9

2.7

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.12

0.17

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.23

0.17

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

104

750

0.95

0.16

1.3

1.4

27.09

59.78

g/l

0.71

575

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

971

6774

0.99

0.15

1.4

1.5

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.85

0.15

3.8

5.8

2.09

1.31

mg/l

—

(3004451) EKG impression Narrative

263

1761

1.03

0.15

1.3

—

(3010503) CD19 cells [#/volume] in Blood

309

2074

1.03

0.15

2.2

2.7

149.95

305.29

e6/l

2.06

297

2022

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

142

1.11

0.15

1.0

0.07

0.48

u/ml

1.69

(3032352) Blasts [#/volume] in Cerebral spinal fluid

369

1.06

0.14

1.7

2.3

—

(3034426) Prothrombin time (PT)

178

1187

1.03

0.14

1.2

28.56

28.09

0.54

178

1187

(3042111) Morphology [Interpretation] in Bone marrow Narrative

733

5118

0.99

0.14

1.5

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

209

1.09

0.14

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

465

0.95

0.14

1.2

1.8

6.02

7.41

mmol/l

2.27

133

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.18

0.14

1.0

1.1

83.00

89.05

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

652

4555

0.98

0.13

5.6

6.5

11.20

11.60

mg/l

1.44

611

4222

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

528

0.95

0.13

4.8

5.6

42.24

44.41

ug/min

0.09

415

(3016228) CD19 cells/cells in Blood

190

1346

0.97

0.13

2.1

8.91

8.31

0.35

182

1316

(3020356) Listeria sp identified in Specimen by Organism specific culture

281

0.93

0.13

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

300

2111

0.98

0.13

1.2

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

130

1.11

0.13

1.0

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

130

1.11

0.13

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

351

1.06

0.12

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

637

4323

1.01

0.12

1.4

1.6

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

144

1.10

0.12

1.0

1.1

0.04

0.36

mg/l

0.52

123

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

180

0.92

0.11

15.0

10.4

742.12

211.86

e6/l

0.38

124

(3006598) pH of Arterial cord blood

164

0.92

0.09

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

517

3516

1.01

0.09

1.5

1.7

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

135

0.92

0.08

1.0

0.04

0.78

u/ml

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

519

1.03

0.08

1.5

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

587

1.03

0.08

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

163

0.93

0.08

1.0

1.1

-1.49

-2.24

mmol/l

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.76

0.08

2.4

2.3

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.09

0.08

1.7

1.0

1.29

1.27

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

606

4210

0.99

0.07

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

644

1.03

0.07

1.8

1.9

2.36

3.43

ug/l

0.54

412

(3006567) Chloride [Moles/time] in 24 hour Urine

0.86

0.07

1.3

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1130

7733

1.01

0.06

3.9

6.2

6145.03

1045.97

iu/ml

0.47

118

1141

(3009871) Measles virus Ab [Titer] in Serum

214

1494

0.99

0.06

1.7

1.6

3253.33

3457.59

titre

0.13

246

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

140

0.93

0.06

1.1

1292.11

4501.91

ng/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

135

946

0.98

0.06

1.2

1.3

39.43

40.04

g/l

0.20

504

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

109

1.07

0.05

1.0

1.1

133.00

230.29

pmol/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.91

0.05

5.5

0.16

0.22

mmol/l

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

591

0.98

0.05

6.0

7.2

69.57

69.62

0.01

447

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

179

1215

1.01

0.05

1.8

2.0

40.55

40.39

g/l

0.13

179

1215

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

289

2007

0.99

0.04

1.5

—

(3017354) Segmented neutrophils/Leukocytes in Blood

510

3531

0.99

0.04

2.6

3.4

56.53

57.08

0.25

428

3054

(3036782) Glucose [Moles/volume] in Pleural fluid

427

2958

0.99

0.04

1.3

6.38

6.25

mmol/l

0.41

401

2752

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

185

1259

1.01

0.04

2.6

2.9

0.62

0.61

mmol/l

0.71

185

1259

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

106

741

0.98

0.04

1.3

1.2

448.53

304.49

pmol/l

0.46

548

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

507

1.02

0.03

1.3

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1368

9440

1.00

0.03

2.7

3.4

3.37

5.64

ratio

0.79

742

5428

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1548

10627

1.00

0.03

2.8

3.5

33.84

41.92

mg/l

2.17

1315

9034

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

262

1791

1.01

0.02

7.6

6.6

544.71

3004.72

u/ml

0.68

334

(3020393) Adenovirus Ag [Presence] in Stool

365

0.98

0.02

1.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

549

3765

1.00

0.02

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1580

10892

1.00

0.02

2.5

2.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.93

0.02

1.0

1.1

1.00

1.33

u/field

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

221

1.03

0.02

1.6

1.7

—

(3013762) Body weight Measured

112

1.04

0.01

1.1

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

119

1.04

0.01

1.1

2.45

1.05

u/field

0.38

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

184

0.97

0.01

1.1

1.2

—

438.57

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.95

0.01

6.6

8.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

305

1.02

0.01

1.3

21.08

21.07

mmol/l

0.00

236

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.05

0.01

1.1

1.2

289.50

275.70

u/ml

0.12

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

694

4782

1.00

0.00

3.0

2.9

106.30

570.50

u/ml

1.43

684

4728

(3026726) Creatinine [Moles/volume] in Specimen

259

0.98

0.00

2.2

2.4

434.70

394.80

umol/l

0.08

251

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

209

1434

1.00

0.00

1.1

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

1.04

0.00

6.3

6.7

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.03

0.00

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

134

1.03

0.00

1.2

1.1

237.30

294.13

nmol/l

0.63

134

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

122

1.02

0.00

1.1

1.3

1.00

1.11

u/field

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

226

1.00

0.00

1.1

1.2

14.22

24.95

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

149

1.02

0.00

1.0

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

176

1.02

0.00

1.3

1.7

0.62

0.71

umol/l

0.55

131

(3045462) Protein/Creatinine [Ratio] in Urine

448

1.00

0.00

4.4

4.0

48.97

50.84

mg/mmol

0.04

402

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.05

0.00

1.2

21.17

30.60

mg/l

1.51

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

218

1.01

0.00

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

174

0.99

0.00

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

246

1.01

0.00

1.3

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

505

0.99

0.00

1.1

1.3

33.95

42.73

mg/l

1.11

434

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

797

5487

1.00

0.00

3.0

3.9

35.99

38.69

u/ml

0.14

767

5298

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.97

0.00

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1547

10644

1.00

0.00

2.8

3.5

47.13

67.34

mg/l

1.35

1311

9049

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

2.3

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

8.78

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.96

-0.00

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.88

-0.00

1.0

1.1

1005.00

2043.83

titre

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.98

-0.00

1.1

1.0

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_SLEEP – Sleep disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sleep disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Sleep disorders (F5_SLEEP)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints